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ABSTRACT
Integrated Modulation of Sympathetic Tone
in the Microcirculation by
Oxygen, Adenosine, and Nitric Oxide
Bryan Auston Sauls
Despite a profound reduction in hemodynamic shear stress, a sustained
release of endothelium-derived nitric oxide (NO) limits arteriolar constriction
during periods of increased sympathetic nerve activity in the rat small intestine.
In this project, we sought to test the hypothesis that adenosine, formed in
response to a flow-dependent fall in local PO2, serves as the stimulus to preserve
endothelial NO release under these conditions. Sympathetic nerve stimulation
induced frequency-dependent arteriolar constrictions and a flow-dependent fall in
local PO2. The arteriolar responses to nerve stimulation were enhanced after
inhibition of NO synthase with NG-monomethyl-L-arginine (L-NMMA). Under a
high (20%) O2 superfusate, the fall in local P O2 during nerve stimulation was
significantly attenuated, arteriolar constrictions were significantly increased, and
these responses were no longer sensitive to L-NMMA.
Treatment with
adenosine deaminase (2.0 U/ml) or the selective A1 receptor antagonist 8cyclopentyl-1,3-dipropylxanthine (4x10 -4 M) completely blocked the enhancing
effect of L-NMMA on sympathetic constriction. In the presence of the 5’ectonucleotidase inhibitor α,β-methyleneadenosine 5´-diphosphate (4.5x10-5 M),
the enhancing effects of L-NMMA and the high-O2 superfusate on sympathetic
constriction were preserved. None of these treatments had an effect on vascular
smooth muscle responsiveness to NO (as judged by arteriolar responses to
sodium nitroprusside). The high-O2 superfusate also did not lead to the
generation of reactive oxygen species in the arteriolar wall (as determined by the
reduction of tetranitroblue tetrazolium dye). In conclusion, these results suggest
that a flow-dependent fall in arteriolar wall and/or tissue PO2 leads to the release
of intracellularly-formed adenosine, which, through its interaction with endothelial
A1 receptors, stimulates NO release during neurogenic constriction in this
vascular bed.
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PREFACE
This dissertation will begin with a review of the literature that constitutes the
scientific foundation on which these studies are based. The three studies that
constitute this dissertation work will then be reported in manuscript form, followed
by a general unified discussion of the findings.

iv

DEDICATION
I would like to dedicate this work and all that I have accomplished to my
family.

Without them, none of this would have been possible.

To my wife

Melanie, you are the star that guides my journey, without you I would be adrift in
a sea of unfulfilled dreams. To our daughter Breanna, you are my elixir of life,
each time I earn your admiration it charges me onward toward the next
challenge. To our son Aidan, your glow touches me in ways that I hope you’ll
understand someday. I thank god everyday that I have been blessed with each
of you.

v

ACKNOWLEDGEMENTS
To start, I would like to thank Dr. Matthew Boegehold for all of his support
and for his faith in me. I am certain that everything I accomplish in the coming
years will be in no small part due to his influence and to the opportunity he
granted me.

Although my path may lead me away from science in the near

future, I will always cherish the lessons that I have learned under his tutelage.
Matt, I am forever in your debt.
I would like to thank my committee, Dr. Chris Baylis, Dr. John Connors, Dr.
Mike Michalkiewicz, Dr. Dave Taylor, and Dr. Stan Yokota for all of their help and
guidance. In particular, I would like to thank Chris Baylis and Stan Yokota for
their considerate comments and suggestions over the years. In addition to my
committee I would like to thank all of the members of the Physiology department
who have worked to create such a wonderful learning environment. I would also
like to thank my fellow graduate students (former and present) who have made
everything a little more bearable: Geoff, Russ, Tim, Debbie, J.J., Jolene, Ron,
Steve, Kevin, Aaron, Patti, Ranja, Jim, and Van.
Finally, I would like to thank my brother, Jim and sisters, Faith, Fran, and
Nedda for all of their love, support, and encouragement. Just knowing that you
were behind me made all of the difference in the world. In closing, I would like to
thank my parents James Ned and Naomi Faith Sauls for defining the parameters
by which I live my life and for always believing that I was capable of anything. To
each of you I give my sincerest gratitude.

vi

TABLE OF CONTENTS
Abstract………………………………………………………………………………......ii
Preface………………………………………………………………………………......iii
Dedication…………………………………………………………………………….....iv
Acknowledgments……………………………………………………………………....v
Table of Contents……………………………………………………………………....vi
List of Figures………………………………………………………………………….viii
Glossary of Abbreviations……………………………………………..……………....xi
I.

Literature Review
1. Introduction………………………………………………………………….1
2. Regulation of Vascular Smooth Muscle Tone.......................................2
A. Endothelium-Dependent Control of Vascular Tone…………...........2
1. Endothelium-Derived Nitric Oxide...............................................7
(a) Nitric Oxide Synthesis...........................................................8
(b) Basal Nitric Oxide Release..................................................11
(c) Stimulated Nitric Oxide Release..........................................13
(d) NO Signaling Pathways in Vascular Smooth Muscle..........15
B. Neural Control of Vascular Tone....................................................17
1. The Intestinal Vasculature and its Innervation..........................17
2. Sympathetic Adrenergic Neuron Content.................................19
3. Modulation of Arteriolar Diameter and Network Blood
Flow by Sympathetic Nerve Activity..........................................20
4. Endothelial Modulation of Sympathetic Tone............................22
(a) Endothelial Metabolism of Norepinephrine..........................23
(b) Endothelium-derived Factors...............................................24
C. Metabolic Control of Vascular Tone...............................................26
1. General Aspects.......................................................................26
2. Regulation of Vascular Tone by Oxygen..................................27
(a) Oxygen Delivery to the Intestine.........................................27
(b) Effects of Alterations in Oxygen Tension
on Vascular Tone................................................................31
3. Regulation of Vascular Tone by Adenosine
and Adenine Nucleotides..........................................................34
(a) A Brief History of Purinergic Signaling.................................34
(b) P1-Purinoceptor Classification and Signaling......................36
(c) P2-Purinoceptor Classification and Signaling......................37
(d) Formation and Release of Adenosine.................................38
(e) The Role of Adenosine in the Regulation
of Vascular Tone.................................................................39

vii

(f) The Role of Adenine Nucleotides in the
Regulation of Vascular Tone...............................................42
II.

Purpose of this Dissertation Project..........................................................44

III.

Study I: Arteriolar Wall PO2 and Nitric Oxide Release
during Sympathetic Vasoconstriction in the Rat Intestine.........................47
A.
B.
C.
D.
E.
F.

IV.

Study II: Reduced PO2 and Adenosine Formation Preserve
Arteriolar Nitric Oxide Synthesis during Sympathetic Constriction
in the Rat Intestine....................................................................................82
A.
B.
C.
D.
E.
F.

V.

Summary.............................................................................................48
Introduction..........................................................................................49
Methods...............................................................................................50
Results.................................................................................................57
Discussion...........................................................................................67
References..........................................................................................75

Summary.............................................................................................83
Introduction..........................................................................................84
Methods...............................................................................................85
Results.................................................................................................91
Discussion.........................................................................................106
References........................................................................................112

Study III. Adenosine Linking Reduced Oxygen to Arteriolar Nitric
Oxide Release in the Intestine in not Formed from Extracellular ATP....118
A.
B.
C.
D.
E.
F.

Summary...........................................................................................119
Introduction........................................................................................120
Methods.............................................................................................121
Results...............................................................................................128
Discussion.........................................................................................139
References........................................................................................146

VI.

General Discussion.................................................................................154

VII.

References for Literature Review and General Discussion.................…164

VIII.

Curriculum Vitae......................................................................................192

viii

LIST OF FIGURES
LITERATURE REVIEW
Figure 1.

Schematic of the intestinal microcirculation.........................18

STUDY I.
Figure 1.

Plot of time course for arteriolar diameter responses to
sympathetic nerve stimulation before and during
exposure to L-NMMA...........................................................61

Figure 2.

Bar graph of arteriolar responses to sympathetic
nerve stimulation before and during exposure
to high-O2 superfusate.........................................................62

Figure 3.

Plot of time course for arteriolar response to
sympathetic nerve stimulation under control
and high-O2 superfusate......................................................63

Figure 4.

Plot of time course for arteriolar wall PO2
measurements during sympathetic nerve stimulation
under control superfusate and high-O2 superfusate............64

Figure 5.

Bar graph of arteriolar response to A23187
in the before and during L-NMMA.......................................65

Figure 6.

Bar graph of arteriolar response to sodium
nitroprusside under control and high-O2 superfusate..........66

STUDY II.
Figure 1.

Bar graph of arteriolar responses to adenosine
before and during L-NMMA.................................................98

Figure 2.

Plot of time course of arteriolar diameter
response to sympathetic nerve stimulation
before and during L-NMMA.................................................99

Figure 3.

Bar graph of arteriolar diameter response to
sympathetic nerve stimulation under control
and high-O2 superfusate....................................................100

ix

Figure 4.

Plot of time course of tissue PO2 during
sympathetic nerve stimulation under
control and high-O2 superfusate........................................101

Figure 5.

Bar graph of arteriolar diameter response to
sympathetic nerve stimulation in the
presence of adenosine deaminase under control
and high-O2 superfusate..................................................102

Figure 6.

Bar graph of arteriolar diameter response to
sympathetic nerve stimulation in the
presence of DPCPX under control
and high-O2 superfusate....................................................103

Figure 7.

Bar graph of arteriolar responses to adenosine
(top panel) or CCPA (bottom panel) before and
during DPCPX...................................................................104

Figure 8.

Bar graph of arteriolar response to sodium
nitroprusside under control and in the presence
of adenosine deaminase (top panel);
and DPCPX (bottom panel)...............................................105

STUDY III.
Figure 1.

Bar graph of arteriolar response to AMP before
and during AOPCP...........................................................132

Figure 2.

Bar graph of arteriolar response to ATP
before and during L-NMMA (top panel)
and DPCPX (bottom panel)...............................................133

Figure 3.

Bar graph of arteriolar response to ATP
before and during exposure to AOPCP
and AOPCP+L-NMMA.......................................................134

Figure 4.

Bar graph of arteriolar diameter response to
sympathetic nerve stimulation in the
presence of adenosine deaminase under control
and high-O2 superfusate....................................................135

x

Figure 5.

Bar graph of arteriolar diameter response to
sympathetic nerve stimulation in the
presence of DPCPX under control
and high-O2 superfusate....................................................136

Figure 6.

First-order linear regression of the
relationship between arteriolar-venular
separation distance and enhancement of
vasoconstriction by L-NMMA or high O2 superfusate........137

Figure 7.

Bar graph of arteriolar response to sodium
nitroprusside before and during exposure to AOPCP.......138

Discussion
Figure 1.

Summary of the results of this project...............................163

xi

GLOSSARY OF ABBREVIATIONS
AA

Arachidonic acid

AC

Adenylyl cyclase

ADO

Adenosine

ADP

Adenosine 5’diphosphate

AOPCP

α,β−methyleneadenosine 5’-diphosphate

ATP

Adenosine 5’tripohsphate

ATPase

Adenosine triphosphatase

BH4

Tetrahydrobiopterin

Ca2+

Calcium

[Ca2+]i

Intracellular calcium concentration

CaM

Calmodulin

cAMP

3’,5’-cyclic adenosine monophosphate

CCPA

2-chloro-N6-cyclopentyl-adenosine

cGMP

3’,5’-cyclic guanosine monophosphate

cGMP-PK

3’,5’-cyclic guanosine monophosphate protein kinase

DAG

Diacylglycerol

DPCPX

8-cyclopentyl-1,3-dipropylxanthine

EDRF

Endothelium-derived relaxing factor

eNOS

Endothelial nitric oxide synthase

FAD

Flavin adenine nucleotide

FMN

Flavin mononucleotide

xii

Gi

Inhibitory G-protein

Gq

Stimulatory G-protein

iNOS

Inducible nitric oxide synthase

IP3

Inositol 1,4,5-triphosphate

K+

Potassium

L-NMMA

NG-monomethyl-L-arginine

MAPK

Mitogen activated protein kinase

mm Hg

Millimeters of mercury

NAD(P)H

Nicotinomide adenine dinucleotide phosphate

NE

Norepinephrine

NO

Nitric Oxide

nNOS

Neuronal nitric oxide synthase

NOS

Nitric oxide synthase

O2

Oxygen

PIP

Phosphatidylinositol-4-phosphate

PIP2

Phosphatidylinositol

PGI2

Prostacyclin

PO2

Partial pressure of oxygen

PKC

Protein kinase C

PLA2

Phospholipase A2

PLC

Phospholipase C

SNP

Sodium nitroprusside

1

LITERATURE REVIEW

I. INTRODUCTION
The primary function of the cardiovascular system is to transport
oxygenated blood from the lungs to the tissues and deoxygenated blood from the
tissues to the lungs. To this end, the cardiovascular system has evolved into an
extremely effective and efficient delivery system.

The distribution of cardiac

output among the different organs is dependent upon a variety of factors that
influence the contractile activity of vascular smooth muscle, and thereby vascular
smooth muscle tone. These factors can be divided into two categories: (1) those
originating within the organ (local or intrinsic factors) (2) those originating from
outside of the organ (central or extrinsic factors). Among the most important
intrinsic influences acting on vascular smooth muscle are endothelium-derived
vasoactive factors, local metabolites, and alterations in transmural pressure (i.e.,
myogenic stimuli).

Extrinsic control of vascular smooth muscle is achieved

primarily by the activity of postganglionic autonomic neurons and by circulating
vasoactive (humoral) factors. The combination of these intrinsic and extrinsic
factors is responsible for the moment-to-moment regulation of arteriolar tone and
the overall distribution of blood flow throughout the vasculature.
Although each of these factors contributes importantly to the regulation of
vascular smooth muscle tone, this review will focus only on those factors most
relevant to the study at hand: endothelium-dependent, neurogenic, and metabolic
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influences. In each of the following sections, a detailed account will be made of
the current scientific evidence relating to the mechanism under discussion.

II.

REGULATION OF VASCULAR SMOOTH MUSCLE TONE

A. ENDOTHELIUM-DEPENDENT CONTROL OF VASCULAR TONE
1. General Aspects.

Prior to the 1980’s the vascular endothelium was

considered to be a relatively inert layer of cells with no major functional
properties.

It is now well documented that endothelial cells are extremely

important modulators of local vascular smooth muscle tone. The microvascular
endothelium can modulate vascular smooth muscle tone by several different
mechanisms. First, studies in vascular beds of several different species indicate
that the endothelium can produce potent vasodilating and/or vasoconstricting
substances,

termed

endothelium-derived

relaxing

factors

(EDRFs)

and

endothelium-derived contracting factors (EDCFs), respectively (Marshall and
Kontos, 1990). Second, the endothelium can act as a physical barrier to certain
blood-borne vasoactive compounds, preventing the passage of certain size
molecules to the underlying vascular smooth muscle cells (Ryan and Ryan,
1982).

Third,

the

endothelium

contains

surface

enzymes

that

can

degrade/inactivate specific vasoactive agents (Ryan et al., 1976; Tesfamariam et
al., 1987; Cohen and Weisbrod, 1988).
The primary mechanism by which the endothelium influences vascular
smooth muscle tone is through the production and release of vasoactive
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substances. The release of endothelium-derived factors can be induced by a
variety of substances, including acetylcholine, the calcium ionophore A23187,
bradykinin, norepinephrine (NE), thrombin, and endothelin, as well as by physical
stimuli such as the shear stress associated with luminal blood flow (Vanhoutte,
1989). Despite a great deal of heterogeneity related to the particular species and
vascular bed (Boegehold, 1998), it is generally accepted that the endothelium
can produce at least three distinct types of vasorelaxing factors. The first factor,
originally named EDRF, was discovered in 1980 by Furchgott and Zawadzki.
This substance, since identified as nitric oxide (NO), causes relaxation of
vascular smooth muscle through activation of soluble guanylyl cyclase and a
subsequent increase in intracellular cyclic guanosine 3´, 5´-monophosphate
(cGMP) (Rapoport and Murad, 1983; Furchgott et al., 1984). The second type of
vasorelaxing factor produced by endothelial cells in a variety of vascular beds is
the vasodilatory prostanoids such as prostacyclin (PGI2) and prostaglandin E2
(PGE2), both of which are derived from arachidonic acid metabolism (Gerritsen,
1987; Bassenge, 1996).

Once released from the endothelium, these factors

stimulate vascular smooth muscle adenylyl cyclase (AC), leading to increased
formation of adenosine 3´,5´-cyclic monophosphate (cAMP) and subsequent
vascular smooth muscle relaxation (Gerritsen, 1987).

However, not all

endothelium-dependent relaxations are dependent on the release of NO or
prostanoids.

Studies conducted by numerous investigators indicate that

endothelium-dependent relaxations can be partially or totally resistant to
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cyclooxygenase and NOS inhibition (Bény and Brunet, 1988; Richard et al.,
1990; Cowan and Cohen, 1991; Illiano et al., 1992; Nagao and Vanhoutte, 1992),
suggesting the existence of a third class of endothelium-derived dilators. This
NO/prostanoid-independent relaxation is preceded by vascular smooth muscle
hyperpolarization, resulting in the closure of voltage-dependent Ca2+ channels
and a subsequent reduction in [Ca2+]i (Fisslthaler et al., 2000).

Due to the

hyperpolarizing effect these substances are known as endothelium-derived
hyperpolarizing factors (EDHF). It is now clear that there are probably several
distinct EDHFs specific to different species and vascular beds. For instance,
inhibition of the cytochrome P450 monooxygenase abolishes EDHF-mediated
responses in bovine and porcine arteries (Bauersachs et al., 1994; Fulton et al.,
1995), but has no effect on the EDHF-mediated responses in rat and guinea pig
blood vessels (Corriu et al., 1996; Fukao et al., 1997). The arachidonic acid
derivative anandamide has been suggested as a possible EDHF in rat mesentery
and heart (Randall et al., 1997), but anandamide has since been rejected as an
EDHF in bovine coronary, rat mesenteric, pig coronary, and guinea pig carotid
arteries (Pratt et al., 1998; Chataigneau et al., 1998). Once released, EDHFs
cause vascular smooth muscle hyperpolarization through the activation of
potassium channels.

In some species, the EDHF response is blocked by

apamin, which suggests the involvement of low conductance Ca2+-dependent K+
channels (Garcia-Pascual et al., 1995; Murphy and Brayden, 1995). In others, a
combination of charybdotoxin (an inhibitor of both large conductance Ca2+-
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sensitive and voltage-sensitive K+ channels) and apamin is required to abolish
the EDHF response (Corriu et al., 1996; Chataigneau et al., 1998).
In addition to releasing vasodilatory agents, the endothelium also releases
agents that promote vasoconstriction. The principal mediators of this response
are certain cyclooxygenase products and endothelin (De Mey et al., 1982).
Vasoconstrictor agents of cyclooxygenase origin include thromboxane A2,
prostaglandin H2 and superoxide anion. In some vessels, arachidonic acid and
calcium ionophore A23187 cause endothelium-dependent contractions that are
prevented by inhibitors of cyclooxygenase and/or thromboxane synthetase
(Katusic et al., 1988; Katusic and Sheperd, 1991).

In other vessels, the

superoxide anion scavenger superoxide dismutase can prevent the endotheliumdependent contraction to A23187 (Katusic and Sheperd, 1991). Endothelial cells
can also produce the peptide endothelin (La and Reid, 1995). Three endothelin
isoforms (ET-1, ET-2, and ET-3) have been identified, with ET-1 the most potent
and prevalent isoform (Haynes and Webb, 1998).

Once released from

endothelial cells, ET-1 binds to one of two different vascular smooth muscle
endothelin receptors, the ETA subtype (ET-1 selective) or the ETB subtype
(nonselective). The binding of ET-1 to either the ETA or ETB receptor produces
G-protein dependent activation of phospholipase C (PLC), which leads to the
hydrolysis of phosphatidyl inositol and generation of inositol 1,4,5-triphosphate
(IP3) (Griendling et al., 1989).

Once generated, IP3 diffuses to the endoplasmic

reticulum where it triggers the release of intracellular calcium (Hirata et al., 1988),
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which, in association with calmodulin, activates myosin light-chain kinase and
enhances vascular smooth muscle contractile activity.

In addition, ET-1 has

been shown to enhance the entry of calcium into the vascular smooth muscle cell
by increasing the conductance of voltage-gated Ca 2+ channels (Kanaide, 1996)
and reducing the conductance of K+ channels (Haynes and Webb, 1993).
The second general mechanism by which the endothelium modulates
vascular smooth muscle tone is through its ability to function as a diffusion
barrier. With its position at the interface of the vessel wall and lumen, this thin
sheet of squamous cells acts as a partially selective diffusion barrier between the
plasma and vascular smooth muscle. As one might imagine, there are regional
and segmental differences in the size and density of endothelial pores, and in the
characteristics of not only the endothelial membrane, but also the junctions
between adjacent endothelial cells. As a result, different-sized molecules may or
may not pass selectively through the endothelium depending on the vessel type.
In general, endothelial cells of peripheral arteries and arterioles are linked by a
combination of tight junctions and gap junctions (Spagnoli et al., 1982).
Endothelial pores and tight junctions can allow ions, small hydrophilic molecules
and proteins up to the size of albumin to pass through to the interstitium (Palade
et al., 1978). In addition, small lipid-soluble substances and lipolysis products
such as diglycerides, monoglycerides and free fatty acids may also cross this
barrier, whereas macromolecules cannot permeate the endothelium and must be
actively transported through the cell (Palade et al., 1978).
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Finally, in addition to its paracrine and barrier functions, the endothelium also
contains surface enzymes capable of degrading, inactivating, or otherwise
transforming vasoactive substances.

For example, endothelial cells contain

angiotensin-converting enzymes that can convert inactive angiotensin I into
angiotensin II as well as degrade bradykinin (Ryan et al., 1976), as well as
monamine oxidase and catechol-O-methyl transferase, which can actively
degrade norepinephrine (Tesfamariam et al., 1987; Cohen and Weisbrod, 1988;
Weiss, 1988). In addition, the endothelium contains 5´-ectonucleotidase,
adenosine deaminase, and adenosine kinase, which are capable of modulating
the local concentrations of ATP and its vasoactive metabolites ADP, AMP, and
adenosine (Pearson and Gordon, 1985; Schrader and Decking, 1996).

2. Endothelium-Derived Nitric Oxide. Although Furchgott and Zawadski
first described EDRF in 1980, it was several years before the precise chemical
nature of this compound was known (Furchgott and Zawadski, 1980). Thanks to
the efforts of Palmer and coworkers, as well as Ignarro and colleagues, the
chemical identity of EDRF was known by 1987. Palmer and coworkers (1987)
identified EDRF as NO on the basis of the reaction between EDRF and ozone to
yield a chemiluminescent product indistinguishable from that yielded by the
reaction between authentic NO and ozone.

Ignarro and colleagues (1987),

employing two different chemical approaches, concluded that EDRF and NO
were either very closely related or the same chemical compound.
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(a) Nitric Oxide Synthesis. Nitric oxide is synthesized by three isoforms of
the enzyme nitric oxide synthase (NOS). To date, these isoforms include, the
constitutively-expressed isoforms NOS I, found mainly in neuronal cells, and
NOS III, expressed mainly in endothelial cells, as well as the inducible isoform
NOS II, first isolated in murine macrophages (Li and Förstermann, 2000). All
three isoforms require heme, flavin adenine dinucleotide (FAD), flavin
mononucleotide (FMN), tetrahydro-L-biopterin (BHT), nicotinamide adenine
dinucleotide phosphate (NADPH), oxygen, and calmodulin (CaM) to be functional
(Marletta, 1988; Marletta, 1993; Knowles and Moncada, 1994; Masters, 1994;
Stuehr, 1997).

All three are also homodimers of a polypeptide in which the

heme- and BHT-binding domain is linked via a CaM-binding sequence to a
flavoprotein with binding sites for one FAD, one FMN, and NADPH (Bredt et al.,
1991; Klatt et al., 1992; McMillan et al., 1992; White and Marletta, 1992). The
isoforms differ in their tissue localization, regulation, and function. For instance,
nNOS is longer than the other isoforms due to the presence of a PDZ region at
the amino terminus that is involved in subcellular targeting of the protein
(Brenman et al., 1995). Similarly, eNOS contains specialized myristolyation and
palmitoylation sites at the amino terminus that serve to stabilize the enzyme at
the cell membrane (Garcia-Cardeña et al., 1996).

Furthermore, nNOS and

eNOS are constitutive enzymes that are regulated by calcium–dependent binding
of CaM to the CaM-binding site. Therefore, their activity is regulated by changes
in [Ca2+]i (Moncada and Higgs, 1993; Nathan and Xie, 1994). In contrast, iNOS
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binds CaM in an essentially calcium-independent manner, with its activity
regulated transcriptionally by cytokines rather than by changes in intracellular
calcium concentration (Cho et al., 1992; Moncada and Higgs, 1993; Natha and
Xie, 1994; Li and Förstermann, 2000).
Upon activation, the three isoforms catalyze the same two-step reaction.
They oxidize L-arginine to the stable intermediate N-hydroxy-L-arginine, and
subsequently oxidize this intermediate to NO and L-citruline (Moncada et al.,
1991; Nathan, 1992). Both of these steps are NADPH- and oxygen-dependent
(Stuehr, 1997; Knowles and Moncada, 1994). The electrons required for the
reaction flow from NADPH to FAD, then to FMN, and finally to the heme iron
atom.

The flow of electrons from FMN to the heme iron is regulated by the

binding of CaM to the CaM-binding site and is therefore the site of calciumdependent regulation of nNOS and eNOS activity (Abou-Soud and Steuhr, 1993;
Garcia-Cardeña et al., 1997).
Nitric oxide synthesis can be stimulated by both receptor-mediated and
receptor-independent mechanisms.

In the receptor-mediated mechanism, an

increase in intracellular free Ca2+ concentration and the subsequent binding of
calcium to CaM is necessary for NOS activation (Ayajiki et al., 1996; Korenaga et
al., 1993; Luckoff et al., 1988).

Some examples of the agonists that can

stimulate NO synthesis include: acetylcholine, ATP, bradykinin, norepinephrine,
serotonin, thrombin, the Ca 2+ ionophore A23187, polycations and calciumATPase inhibitors (Ayajiki et al., 1996; Busse et al., 1993; Hecker et al., 1992;
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Korenaga et al., 1993).

Although the precise mechanism by which these

substances stimulate NO synthesis has not been fully elucidated, several key
steps have been.

Upon binding to their respective receptors, these agonists

initiate a cascade that involves the activation of receptor-coupled G proteins that
subsequently

activate

phospholipase

C

and

initiate

the

hydrolysis

of

phophatidylinositol bisphosphate (PIP2) into diacylglycerol (DAG) and inositol1,4,5-trisphosphate (IP3) (Adams, 1989). Once generated, IP3 diffuses to the
endoplasmic reticulum where it binds to its receptor and promotes the release of
Ca2+ from intracellular stores (Bredt and Snyder, 1991).

The release of

intracellular Ca2+ contributes to the initial rise in cytosolic Ca2+ levels, but its most
important role is to enhance extracellular calcium entry into the cell (Ayajiki et al.,
1996; Korenaga et al., 1993; Luckoff et al., 1988) by promoting membrane
hyperpolarization through the activation of calcium-activated K+ channels.
Ultimately, this cascade results in a substantial increase in [Ca 2+]i, thus promoting
the formation of the calcium/CaM complex.
In at least one receptor-independent mechanism of endothelial NO
synthesis, the response to hemodynamic shear stress, NO synthesis is only
transiently dependent on the intracellular Ca 2+ concentration (Muller et al., 1999).
Just as with agonist-dependent NOS activation, agonist-independent NOS
activation appears to involve activation of endothelial membrane G proteins
(Gudi et al., 1996; Kuchan et al., 1994) which are responsible for the activation of
phospholipase C and a subsequent increase in intracellular IP3 levels (Nollert et
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al., 1990; Prasad et al., 1993).

As stated above, IP3 can diffuse to the

endoplasmic reticulum where it promotes the release of intracellular Ca2+ stores
(Bredt and Snyder, 1991). Once released, this Ca2+ promotes the entry of Ca2+
from outside the cell possibly by the activation of an outward potassium current
(Olesen et al., 1988). Together, these responses promote an increase in [Ca 2+]i
that may provide an important rapid component to the endothelial response to
elevated hemodynamic shear.
The sustained release of NO during increased shear stress does not require
an increase in intracellular Ca2+, but rather depends on the phosphorylation of
eNOS by tyrosine and serine/threonine kinases (Ishida et al., 1996; Muller et al.,
1999; Fisslthaler et al., 2000).

In recent years, various elements of known

signaling pathways have been studied in an attempt to elucidate the mechanism
of endothelial shear stress transduction. Ishida and coworkers (1996) found that
both flow and β1 integrin activation stimulate protein tyrosine phosphorylation,
mitogen-activated protein kinase (MAP) kinase, and focal adhesion kinase (FAK)
in human umbilical vein endothelial cells (HUVEC). Also working with HUVECs,
Pearce and colleagues (1996) found that, in addition to activating MAP kinase,
shear activates cytosolic phospholipase A2 (cPLA 2). Shear-dependent activation
of K+ channels and stretch-activated Ca 2+ channels has also been reported as a
possible mechanism for signal transduction (Davies, 1995; Jo et al., 1997).
(b) Basal Nitric Oxide Release.

Many investigators have reported that

there is a basal release of NO from the vascular endothelium (Griffith et al., 1984;
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Förstermann et al., 1985; Martin et al., 1986; Bohlen, 1998b; Lash and Bohlen,
1999; Bohlen and Nase, 2000; Bohlen and Nase, 2001; Nase and Bohlen, 2001).
For example, using a NO-sensitive microelectrode, Bohlen demonstrated that
small arteries and arterioles in the rat intestine continuously release NO (Bohlen,
1998b; Bohlen and Nase, 2000; Bohlen and Nase, 2001; Nase and Bohlen,
2001). The overall importance of basal NO release in cardiovascular regulation
is illustrated by findings that systemic NOS inhibition with the L-arginine analog
L-NMMA significantly increases arterial blood pressure, and that this effect is
reversed by L-arginine (Rees et al., 1989; Gardiner et al., 1990; Baylis et al.,
1992).

In-vivo microscopy has revealed that NOS inhibition with various L-

arginine analogs also significantly increases resistance vessel tone in several
vascular beds (Hester et al., 1993; Boegehold, 1995; Friebel et al., 1995; Pries et
al., 1995; Bohlen and Lash, 1996).

However, NOS inhibition does not affect

vascular tone in every vascular bed or vessel segment (Nase and Boegehold,
1996; Nurkiewicz and Boegehold, 1999). While these latter findings indirectly
suggest that some vascular beds lack basal NO release, it is important to realize
that this may not necessarily be true. Since resting arteriolar tone is the result of
vascular smooth muscle’s integration of numerous ongoing vasoactive signals,
changes in the activity of any of these signals may be accompanied by changes
in the other signals, thereby preserving the level of tone.
The intrinsic stimulus for tonically released NO is not known for certain,
but recent studies suggest that a prime candidate is hemodynamic shear stress
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(Bohlen and Lash, 1996; Bohlen and Nase, 2000). It is well documented that
shear-induced release of NO is important in mediating the local arteriolar dilation
in response to acute increases in blood flow (Boegehold, 1995), and it is also
possible that resting blood flow acts as a continuous background stimulus for
vasodilation (Robard, 1975).

Bohlen and Nase (2000) demonstrated that

collateral occlusion of first-order arterioles increases parallel arteriolar blood flow,
diameter, and shear rate by 90%, 10%, and 20%, respectively.

This 20%

increase in shear rate translated into a 40% increase in periarteriolar NO
concentration.

Based on this and other evidence, Bohlen and Nase (2000)

concluded that 60-80% of the basal NO release in rat intestinal arterioles was
due to the influence of shear stress on the endothelium.
(c) Stimulated Nitric Oxide Release. In addition to the basal release of
endothelial NO, its synthesis can be enhanced in virtually every vascular bed by
receptor-dependent

agonists

such

as

acetylcholine,

adenosine,

ATP,

norepinephrine and bradykinin (Koller et al., 1989; Nakumura and Prewitt, 1991;
Korenaga et al., 1993; Ayajiki et al., 1996) and receptor-independent agonists
such as calcium ionophores (Busse et al., 1993). For any of these agonists to
increase eNOS activity, it is absolutely necessary for them to somehow elevate
[Ca2+]i (Muller et al., 1999). As mentioned above, agonist-induced increases in
[Ca2+]i can be achieved by a transient IP3-mediated release of intracellular Ca2+
and a more sustained transmembrane influx of Ca2+ from the extracellular space.
A number of studies have found that removal of extracellular Ca2+ inhibits
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bradykinin-, thimerosal-, ATP-, and acetylcholine-induced NO synthesis (Luckoff
et al., 1988; Korenaga et al., 1993; Ayajiki et al., 1996), verifying that it is the
influx of Ca2+ from the extracellular space that drives NO synthesis in response to
these agonists.
Other factors such as fluid shear stress (Boegehold, 1995; Bohlen and
Nase, 2000; Friebel et al., 1995), and decreases in perivascular PO2 (Blitzer et
al., 1996; Pohl and Busse, 1989; Pries et al., 1995) can also enhance NO
synthesis. Hemodynamic shear stress has been shown to contribute importantly
to the control of vascular resistance in the intact arteriolar networks of skeletal
muscle (Boegehold, 1995), the intestine (Bohlen and Lash, 1996; Bohlen and
Nase, 2000) and the mesentery (Smiesko et al., 1989). Hemodynamic shear
stress contributes importantly to the maintenance of basal NO release, but it also
represents an important mechanism by which individual vessels can modulate
their own resistance in response to changes in either the upstream or
downstream resistance. Following an acute change in luminal flow, there is an
initial phase during which vascular diameter does not change, leading to either
an increase or decrease in shear stress on the endothelial cell membrane (Koller
and Kaley, 1990a).

This change in shear stress elicits the increased or

decreased release of relaxing factors from the endothelium, resulting in
vasodilation or vasoconstriction and a partial restoration of wall shear stress
toward control levels (Smiesko et al., 1989; Koller et al., 1994; Boegehold, 1995).
In addition to sensing mechanical forces such as shear stress, the vascular
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endothelium may also act as a local sensor and effector system for the regulation
of tissue oxygen supply. For a full review of this topic, please see section C:
Metabolic Control of Vascular Tone.
(d) Nitric Oxide Signaling Pathways in Vascular Smooth Muscle. Once
formed, NO quickly diffuses into the vascular smooth muscle cytoplasm where it
binds to and activates soluble guanylyl cyclase (Katsuki et al., 1977), which
catalyzes the conversion of GTP to cGMP. Cyclic GMP then activates cGMPdependent protein kinase (cGMP-PK), which promotes vascular smooth muscle
relaxation principally by lowering [Ca2+]I (Lincoln and Cornwell, 1993).
Depending on the species and vascular bed, cGMP could affect [Ca2+]i in up to
four different ways: (1) by reducing the influx of extracellular Ca2+, (2) by
increasing the efflux of intracellular Ca2+, (3) by promoting Ca2+ sequestration in
the sarcoplasmic reticulum, and (4) by decreasing the release of Ca2+ from
intracellular stores. Cyclic GMP-dependent mechanisms have been shown to
reduce Ca 2+ influx via inhibition of voltage-dependent L-type Ca2+ channels either
through a direct reduction of channel activity or by hyperpolarization of the
vascular smooth muscle membrane due to increased KCa channel activity (Archer
et al., 1994; Carrier et al., 1997; Ruiz-Velasco et al., 1998). Increased efflux of
Ca2+ from the vascular smooth muscle may be accomplished by activation of the
plasma membrane Ca2+-pumping ATPase and the Na +/Ca 2+ exchanger.

The

driving force for Ca2+ removal from the cell by the Na +/Ca 2+ exchanger, in turn,
may be dependent on the depletion of intracellular Na+ via activation of Na +-K+
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ATPase.

The Ca 2+-pumping ATPase and the Na +/K+ ATPase in the plasma

membrane are activated by cGMP through cGMP-PK (Yoshida et al., 1992;
Tamaoki et al., 1997a). Cyclic GMP promotes sequestration of Ca2+ by activating
the sarcoplasmic reticulum Ca2+-pumping ATPase (Andriantsitohaina et al.,
1995). The molecular mechanism underlying this effect appears to be cGMP-PK
phosphorylation of phospholamban, as demonstrated by Sabine and colleagues
(1995). Finally, cGMP has also been shown to limit mobilization of intracellular
Ca2+ by inhibiting the IP3 signal transduction pathway.

Various investigators

have reported that cGMP blocks agonist-induced IP3 formation and induces
cGMP-PK-mediated phosphorylation of the IP3 receptor in the sarcoplasmic
reticulum, which substantially reduces the affinity of these receptors for IP3 (Ruth
et al., 1993; Komalavilas and Lincoln, 1994; Komalavilas and Lincoln, 1996).
In addition to its effect on Ca2+ homeostasis, NO has been shown to
promote vasodilation through activation of vascular smooth muscle K+ channels
(Murphy and Brayden, 1995; Corriu et al., 1996; Yuan et al., 1996; Li et al., 1997;
Zhao et al., 1997). NO has been shown to hyperpolarize the underlying vascular
smooth muscle through the activation of ATP-sensitive K in rabbit mesenteric
arteries (Murphy and Brayden, 1995) and in guinea-pig carotid artery (Corriu et
al., 1996). In the bovine coronary artery, NO promotes hyperpolarization and
relaxation through the activation of both large conductance Ca 2+-activated K+
channels and delayed rectifier K+ channels (Li et al., 1997).
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B. NEURAL CONTROL OF VASCULAR TONE.
1. The Intestinal Vasculature and its Innervation.

As shown in Figure 1

(next page), the small intestine of the rat is composed of three layers, the
mucosa where nutrients are absorbed, the submucosa where glandular tissue is
located, and the visceral smooth muscle that mixes and propels the food
(Bohlen, 1998a).

Microvascular perfusion of these layers originates from

branches of the superior and inferior mesenteric arteries, and these small feed
arteries supply first-order arterioles that penetrate both muscle layers of the
muscularis externa (Bohlen, 1995). These arterioles then give rise to secondorder arterioles, which form anastomoses between adjacent first-order arterioles.
Second-order arterioles in turn give rise to third-order arterioles that perfuse the
individual arterioles of one or more mucosal villi (Bohlen, 1998). Third-order
arterioles also give rise to fourth-order arterioles, which ascend through the
muscle layers and ultimately give rise to fifth-order arterioles that supply the
capillaries of the longitudinal muscle. The venular drainage mirrors the arteriolar
inflow system. The capillaries converge into fourth-order venules, which supply
third-order venules. The third-order venules then descend through both muscle
layers and drain into second-order venules. Finally, the second-order venules
drain into first-order venules, which return the blood to the small mesenteric
veins.
All of the available evidence indicates that neurogenic constriction of
arterioles in the small intestine results solely from the activation of extrinsic
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Figure 1. Microvascular branching pattern in the rat small intestine. Arterioles
are consecutively numbered from largest to smallest branches; SA and SV are
the small artery and vein that run parallel to the mesenteric border of the bowel
and are in turn perfused by arteries in the mesentery.
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sympathetic nerves, which originate in the prevertebral celiac and mesenteric
ganglia (Furness and Costa, 1987; Hirst, 1989; Surprenant; 1994). In the rat,
cat, guinea pig, and rabbit, these sympathetic vasoconstrictor neurons have been
shown to densely innervate intestinal arterioles while only sparsely innervating
intestinal veins and venules (Furness, 1971; Silva et al., 1971). This pattern of
innervation allows for neurogenic constriction along the entire network of the
arteries and arterioles (Furness, 1971; Silva et al., 1971), resulting in a
considerable rise in vascular resistance.

2.

Sympathetic Adrenergic Neuron Content.

The concept of co-

transmission was originally presented by Burnstock (1976) who, through
comparative studies on the evolution of the autonomic nervous system, provided
evidence that ATP acts as a co-transmitter with NE in sympathetic nerves. The
co-existence of different neurotransmitters within sympathetic nerve terminals is
now widely accepted, and a number of potential co-transmitters have been
identified, including ATP and neuropeptide Y (NPY). However, the significance
of these co-stored agents for the regulation of vascular tone is a subject of great
debate that goes beyond the scope of this review. Therefore, I will limit this
discussion to those most relevant to the study at hand.
In most blood vessels that have been studied, a purinergic component of
sympathetic neurogenic vasoconstriction has been demonstrated, but the relative
contributions of ATP and NE to the response varies greatly among blood vessels.
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For instance, ATP only makes about a 10% contribution to peak constriction of
the rat tail artery (Bao et al., 1993), whereas ATP is totally responsible for the
neurogenic constriction in the rabbit mesenteric artery (Ramme et al., 1987).
Within the intestinal circulation, both NE and ATP play a major role in neurogenic
vasoconstriction. In submucosal arterioles, neurogenic vasoconstriction is
mediated almost entirely by the binding of ATP to P2x -purinoceptors located on
the vascular smooth muscle (Evans and Surprenant, 1992; Surprenant, 1994).
However, in the larger arterioles of the circular muscle layer, NE appears to be
the primary mediator of neurogenic vasoconstriction (Nase and Boegehold, 1996;
Nase and Boegehold, 1998).

One possible determinant of the relative

contributions of ATP and NE to neurogenic constriction is the frequency of nerve
stimulation (Kennedy et al., 1986; Bao et al., 1993). In the rabbit ear artery, ATP
plays a much more prominent role than NE at low nerve stimulation frequencies,
whereas the role of NE progressively increases as nerve stimulation frequency
increases (Kennedy et al., 1986).

3.

Modulation of Arteriolar Diameter and Network Blood Flow by

Sympathetic Nerve Activity.

Tonic sympathetic nerve activity contributes

importantly to the maintenance of resting arteriolar tone in the intestine (Folkow,
1964) and in a number of vascular beds (Bohlen and Gore, 1977; Laurikainen et
al., 1997; Villanueva et al., 1994; Bevan et al., 1993). In the intestine, Folkow
(1964) indirectly determined that the resting discharge rate of sympathetic nerves

21

innervating the vasculature ranges between 1 and 3 Hz, and that these discharge
rates can increase to as much as 8-10 Hz during reflex activity.

Folkow’s

inference about the resting discharge rates of these nerves has been confirmed
by direct measurement of postganglionic sympathetic fiber discharge rates (Kollai
and Koizumi, 1980).
During periods of increased sympathetic nerve activity, there is an
increase in vascular resistance throughout the network and a subsequent
reduction in network blood flow. For example, in the rat intestine, sympathetic
nerve stimulation induces frequency-dependent arteriolar constrictions that
persist throughout the stimulation period (Bohlen et al., 1978; Nase and
Boegehold, 1996; Nase and Boegehold, 1997a, Nase and Boegehold, 1997b;
Nase and Boegehold, 1998).

In other vascular beds sympathetic nerve

stimulation causes a transient vasoconstriction followed by a return of some
vessel diameters to near resting levels, possibly in response to changes in local
metabolite or oxygen levels (Eriksson and Lisander, 1972; Folkow et al., 1971;
Furness and Marshall, 1974; Marshall, 1982; Boegehold and Johnson, 1988a;
Boegehold and Johnson, 1988b; Pal et al., 1998; Lautt et al., 1988).
Studies in various vascular beds have revealed segmental differences in the
response to sympathetic nerve stimulation.

Furness and Marshall (1974)

reported that all arterioles of the rat mesentery constrict by 25-75% during
sympathetic nerve stimulation with the exception of precapillary arterioles, which
do not respond. Working in the cat sartorius muscle, Boegehold and Johnson
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(1988b) also found segmental differences in the vascular response to
sympathetic nerve stimulation, with the fourth-order arterioles constricting to a
greater degree than either more proximal or more distal arterioles. In the rat
intestine, Bohlen and colleagues (1978) demonstrated that sympathetic nerve
stimulation induces a greater increase in second- and third-order arteriolar
resistance than fourth- and fifth-order arteriolar resistance. More recently, Nase
and Boegehold (1996) found that sympathetic nerve stimulation reduces secondorder arteriolar diameter by 29-71% while only reducing first-order arteriolar
diameter by 20-52% and small feed artery diameter by 13-47%.
In the rat intestine, the effect of increased sympathetic nerve activity on
blood flow depends on the stimulation frequency and the vessel type.

For

example, Bohlen and colleagues (1978) found that sympathetic nerve stimulation
at 4 Hz has no effect on arteriolar blood flow in the mucosa, whereas stimulation
at 8 and 16 Hz produced a frequency-dependent reduction in serosal blood flow
with mucosal blood flow reduced by 43- 70% (Bohlen et al., 1978). In the circular
muscle layer, Nase and Boegehold (1996, 1998) found that sympathetic nerve
stimulation at 3-16 Hz reduced flow in small feed arteries by 47-91% and in firstorder arterioles by 33-92%.

4. Endothelial modulation of sympathetic tone.

There are at least two

mechanisms by which the endothelium can limit sympathetic adrenergic
constriction. First, the endothelium can limit sympathetic adrenergic constriction
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by participating in the uptake and extraneuronal metabolism of neurally-released
NE (Rorie, 1982; Tesfamariam et al., 1987; Cohen and Weisbrod 1988).
Second, the endothelium can release substances such as NO and vasodilator
prostanoids that in turn attenuate adrenergic constriction (Kadowitz et al., 1971;
Hedqvist, 1972; Martin et al., 1986; Tesfamariam and Halpern, 1987;
Tesfamariam et al., 1987; Cohen and Weisbrod, 1988; Greenberg et al., 1989;
Chatziantoniou and Arehdshorst, 1992; Ohyanagi et al., 1992; Jones et al., 1993;
Schwarz et al., 1995; Thomas and Victor, 1998; VanVlack et al., 1998;
Mendizabal et al., 1999; Smith et al., 1999; Costa et al., 2001).
(a) Endothelial Metabolism of Norepinephrine.

After its release, NE is

removed from the vasculature by a number of different processes, including its
deactivation by the enzymes catechol-O-methyltransferase and monoamine
oxidase (Rorie, 1982; Tesfamariam et al., 1987; Cohen and Weisbrod 1988). By
metabolizing NE, these enzymes reduce the effective concentration of NE at its
postjunctional receptors and thereby limit the increase in vascular tone. Rorie
(1982) demonstrated that in the canine pulmonary artery pretreated with tritiated
NE, endothelial metabolism of NE is significantly reduced when extraneuronal
uptake of NE is inhibited and that removal of the endothelium reduced the
amounts of O-methylated NE metabolites collected during adrenergic stimulation.
Tesfamariam and colleagues (1987) reported that removal of rabbit carotid artery
endothelium augments nerve stimulation-induced constriction, and that inhibition
of NE metabolism and extraneuronal uptake with cocaine, hydrocortisone and
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parglyine augments the adrenergic constriction of endothelium-intact segments
more than endothelium-denuded segments.

In addition, they found that the

combined inhibition of guanylyl cyclase and NE disposition abolished the
difference between the responses of endothelium-intact and endotheliumdenuded segments. Cohen and Weisbrod (1988) demonstrated that NE overflow
was significantly greater in endothelium-denuded arteries than in endotheliumintact arteries. They also demonstrated that addition of cocaine, hydrocortisone
and parglyine significantly enhanced NE overflow in endothelium-intact arteries
without an appreciable effect on endothelium-denuded arteries. Taken together,
the above studies suggest that reduction of NE concentration by endothelial cell
enzymes is sufficient to attenuate adrenergic constriction in the absence of any
other intervention.
(b) Endothelium-derived factors.

As stated above, endothelium-derived

factors, including NO and vasodilator prostanoids, have been shown to limit
neurogenic constriction in a variety of vascular beds.

However, in the rat

intestine, vasodilator prostanoids do not appear to play a role in the
endothelium’s ability to modulate neurogenic constriction (Nase and Boegehold,
1997). Therefore, for the purpose of this discussion, I will only consider the role
of NO in modulating neurogenic constriction.
Historically the role of NO in the modulation of neurogenic tone has
been explored by evaluating the effects of NOS inhibition, NO scavenging, and/or
endothelial removal on the vascular response to exogenous NE application or to
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the release of neuronal NE by electrical field stimulation. In one of the earliest
studies conducted along these lines, Martin and colleagues (1986) found that the
application of exogenous NE increases rat and rabbit aortic ring tension
significantly more in endothelium-denuded segments than in endothelium-intact
segments, and that the NO scavenger hemoglobin abolishes this difference.
Also in the rat aorta, Ayotunde and Triggle (1993b) found that endothelial
removal enhances the response of ring segments to exogenous NE, and that the
NOS inhibitors L-NMMA and L-NAME, but not their D-isomers, also enhance the
responsiveness of endothelium-intact segments to exogenous NE. Working in
the canine epicardium, Jones and colleagues (1993) found that L-NMMA
significantly enhances the responsiveness of large arterioles to exogenous NE.
Most recently, Mendizabal and colleagues (1999) demonstrated that NO
attenuates the constrictor response to exogenous NE in the perfused rat
mesentery.
Electric field stimulation has been used to investigate the modulation of
sympathetic tone by a number of different investigators.

In isolated rat

mesenteric and femoral arteries, Urabe and colleagues (1991) found that the
response of endothelium-intact ring segments to transmural nerve stimulation
was potentiated by NO scavenging with methylene blue or by endothelial
removal. In the rat caudal artery, Phong and colleagues (1992) reported that
treatment with L-NAME, hemoglobin or methylene blue enhances sympathetic
nerve-induced constriction in endothelium-intact but not endothelium-denuded
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vessels.

More recently, King-VanVlack and colleagues (1998) found that L-

NAME enhances the increase in vascular resistance that accompanies
sympathetic nerve stimulation in the canine gastrocnemius muscle.

While

studying the effect of exercise on sympathetic vasoconstriction in the rat
hindlimb, Thomas and Victor (1998) found that L-NAME partially reversed the
limiting influence of exercise on neurogenic constriction, thus resulting in an
enhanced sympathetic vasoconstriction in contracting hindlimb.

Of particular

interest to the study at hand, Nase and Boegehold (1996) found that inhibition of
NOS with L-NMMA enhances arteriolar responses to sympathetic nerve
stimulation in the rat intestine. In a subsequent study, they found that functional
inactivation of the endothelium with a microembolism also enhances the vascular
response to sympathetic nerve stimulation, with no further enhancement by LNMMA (Nase and Boegehold, 1997).

C. METABOLIC CONTROL OF VASCULAR TONE.
1. General Aspects. The relationship between tissue metabolic activity and
blood flow has been recognized for well over a century (Gaskell, 1876a; 1876b)
with blood flow increasing in proportion to the metabolic demands of the tissue.
In skeletal muscle, there is a positive correlation between tissue blood flow and
muscle contraction frequency (Hilton et al., 1978; Mackie and Terjung, 1983),
and between tissue blood flow and muscle oxygen consumption (Mohrman,
1982; Mohrman and Regal, 1988).

Because of this relationship between
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metabolic activity and blood flow, it has been hypothesized that the local
metabolic state of the tissue directly affects blood flow by altering arteriolar tone
and therefore vascular resistance. To date, the vasoactive properties of a variety
of biochemical compounds have been studied in pursuit of elucidating the
mechanism of metabolic regulation.

The remainder of this section will be an

overview of some likely mediators of this metabolic modulation that are most
relevant to the study at hand.
2. Regulation of Vascular Tone by Oxygen.
(a) Oxygen delivery to the intestine.

The transport of oxygen from the

atmosphere to the mitochondria can be divided into two stages. The first stage
consists of the movement of oxygen from the lung alveoli to the microcirculation
within a tissue, and the second stage is the transfer of oxygen from the red blood
cell (RBC) to the cell mitochondria.

Oxygen moves from the alveoli into the

pulmonary capillaries by passive diffusion. The transfer of oxygen from air to
blood is altered by ventilation/perfusion abnormalities and by changes in inspired
oxygen concentration (Wilson et al., 1977). In the pulmonary capillary blood,
oxygen binds to hemoglobin in a four stage chemical process resulting in the
sigmoid shaped oxyhemoglobin dissociation curve.

From the lungs, blood is

transported to the tissue capillaries by the pumping action of the heart. The
second stage of oxygen transport comprises numerous cellular and subcellular
processes, such as (1) microvascular control mechanisms that match blood flow
with tissue metabolic requirements, (2) the diffusion of oxygen from hemoglobin
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to the tissues, and (3) the rate of cellular oxygen utilization (Renkin, 1984). The
major determinants of this second diffusive stage are, tissue metabolic rate, the
density of perfused capillaries, local vascular resistance, oxygen consumption
rate, oxygen extraction, and ATP production.
In the microvessels, oxygen dissociates from hemoglobin and moves into
the tissues by passive diffusion (Krogh, 1919).

This oxygen exchange is

influenced by many factors (Pittman, 1986). For example, capillary hematocrit is
as much as 50% lower than systemic hematocrit (Sarelius and Duling, 1982).
Variations in capillary hematocrit provide the microvasculature with yet another
control mechanism to ensure an appropriate delivery of oxygen into the tissues.
As demonstrated by Desjardins and Duling (1987), capillary hematocrit can vary
widely with increases in tissue oxygen demand. Microscopic studies also show
that the RBCs tend to follow the path of highest flow. In other words, at capillary
bifurcations, the capillary with the greater blood flow also has a greater
hematocrit (Fung, 1973; Gaehtgens, 1984), thus providing an excellent system
for channeling oxygen to the place where the need is greatest.
Capillary hematocrit (Duling and Desjardins, 1987) and flow (Gutierrez et
al., 1988; Ivanov et al., 1985) influence other microvascular parameters that are
important for tissue oxygenation, such as RBC velocity, intracapillary P O2, and
the space between the RBCs. The velocity and path taken by the RBCs in the
capillary network determine their transit time through these exchange vessels
(Sarelius and Duling, 1982; Tyml et al., 1981).

In well-oxygenated tissues,
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changes in capillary transit time probably have little influence on gas exchange.
However, under conditions of severe hypoxia or greatly elevated metabolic rate,
the time needed by the RBCs to release oxygen may decrease, thereby
increasing the rate of capillary oxygen delivery (Gutierrez, 1986; Honig and
Odoroff, 1984). Microscopic flow studies have shown that RBCs tend to take the
longest path through a given capillary network, thereby maximizing capillary
transit time (Sarelius, 1986).
Capillary recruitment is a mechanism by which the microvasculature can
rapidly increase the surface area available for oxygen exchange (Honig et al.,
1980). In some tissues, a large fraction of the available capillaries are closed
and do not participate in oxygen transport under resting conditions.

The

proportion of capillaries open at any given time in resting dog gracilis muscle has
been estimated at 40% (Bordeau-Martini et al., 1974), a number that increases in
a graded fashion in response to exercise or hypoxia. In addition to increasing the
vascular surface area available for exchange, capillary recruitment also promotes
oxygen delivery by decreasing the mean diffusion distance from a perfused
capillary to any given parenchymal cell.
August Krogh (1919) was the first to quantify the diffusion of oxygen from
the microvasculature to various tissues. Krogh reasoned that oxygen diffuses in
a radial fashion from the center of the capillaries into the tissues. In cooperation
with the mathematician Erlang, Krogh proposed a mathematical model that was
later modified by Kety (1957) and Tenney (1974). In the modified model, oxygen
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transport takes place in a capillary of cylindrical geometry as blood moves from
the arterial to the venous end. The major determinants of oxygen diffusion in this
model are as follows: the difference between capillary and tissue oxygen
pressures, the tissue oxygen diffusion coefficient, the radius of the capillary, and
the diffusion distance. According to Krogh’s model, tissue PO2 declines radially
outward from the capillaries and along the length of the capillary. The cylindrical
model predicts that the highest and the lowest tissue PO2 levels will be around
the arterial and venous ends, respectively. The region with the lowest tissue PO2
is called the “lethal corner.” Those cells located in the “lethal corner” should be
the first to experience the effect of hypoxia.
The capillaries are not the only site of O2 exchange between the tissue and
the circulation.

Oxygen delivery to the tissues occurs throughout the entire

circulation and is the consequence of a balance between the velocity at which O2
is carried by the blood and the rate at which O2 leaks out of the blood vessels
(Ellsworth and Pittman, 1990; Mirhashemi et al., 1987). Studies conducted by
Duling and Berne (1970) indicate that about one-third of arterial O2 exits the
circulation prior to arrival at the capillaries. Similar magnitudes of oxygen loss
from arterioles have been found in the pial microcirculation (Duling et al., 1979;
Ivanov et al., 1982).

In the hamster skinfold, Torres and colleagues (1996)

reported that intraluminal PO2 decreased longitudinally from 58 mm Hg in firstorder arterioles to 35 mm Hg in fourth-order arterioles.
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(b) Effects of alterations in oxygen tension on vascular tone.

Although

oxygen’s ability to modulate vascular tone has been recognized for decades, the
precise mechanism by which oxygen exerts this influence has not been
elucidated.

Some studies suggest that oxygen may have a direct effect on

vascular smooth tone by influencing the activity of smooth muscle cell ion
channels (Gebremedhi et al., 1994; Welsh et al., 1998; McCulloch et al., 1999).
For instance, in cat cerebral arteries, Gebremedhin and coworkers (1994) found
that hypoxia increased the activity of calcium-sensitive potassium channels,
thereby inducing smooth muscle cell hyperpolarization and relaxation. Similarly,
studies conducted in rat renal and cremaster muscle microvessels suggest that
reduced

oxygen

levels

may

lead

to

reduced

formation

of

20-

hydroxyeicosatetraenoic acid, a constitutively-produced cytochrome P-450
metabolite that normally acts as a potent vasoconstrictor (Harder et al., 1996).
However, Welsh and colleagues (1998) found that hyperoxia increases vascular
tone in hamster cheek pouch arterioles by activating L-type calcium channels.
Taken together, these results suggest that alterations in oxygen tension can act
directly at the level of the vascular smooth muscle to either increase or decrease
vascular tone, depending on the prevailing oxygen tension.
In addition to having a direct effect on vascular tone, changes in oxygen
tension have been shown to exert a considerable influence on the release of
endothelium-derived vasoactive factors (Busse et al., 1983; Pohl and Busse,
1989; Myers et al., 1991; Okada, 1991; Gräser and Rubanyi, 1992; Messina et

32

al., 1992; Park et al., 1992; Busse et al., 1993; Fredricks et al., 1994; Blitzer et
al., 1996; Jimenez, 1996; Ward, 1996; Bryan and Marshal, 1999a; Bryan and
Marshall, 1999b). In one of the earliest studies conducted on the subject, Busse
and coworkers (1983) found that removal of the endothelium abolishes the
dilatory response of isolated rat tail and canine femoral arteries to intraluminal
hypoxia.

Furthermore,

incubation

with

the

cyclooxygenase

inhibitor

indomethacin, significantly attenuated this dilatory response to hypoxia,
suggesting that prostacyclin may be a mediator of this response. In support of
this finding, other investigators have reported that treatment with indomethacin
completely abolishes the hypoxic dilation of vessels from canine heart (Myers et
al., 1991), rat heart (Okada et al., 1991), and rat cremaster muscle (Messina et
al., 1992), as well as the rat middle cerebral artery and femoral arteries
(Fredricks et al., 1994a; Fredricks et al., 1994b).
The role of NO in the vascular response to hypoxia was not elucidated until
the late nineteen-eighties. Then, in what has become the seminal work on the
role of NO in hypoxic vasodilation, Pohl and Busse (1989) demonstrated that
hypoxia stimulates NO release in isolated rabbit aorta and femoral artery
segments. In their study, Pohl and Busse found that exposure of endotheliumintact vessel segments to hypoxia promotes a vasodilation that is completely
abolished by hemoglobin, whereas exposure of endothelium-denuded segments
to hypoxia produces no effect.

Furthermore, exposure of an endothelium-

denuded segment to the effluent of cultured endothelial cells that had been
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exposed to hypoxia results in dilation of the vessel segment, and this dilation can
be significantly attenuated by the use of a delay coil to allow time for the
metabolic inactivation of NO.

Over the past decade, a considerable body of

evidence has been collected in support of Pohl and Busse’s findings.

For

example, hypoxia has been shown to increase NO synthesis in a variety of
vessels and vascular beds including rat aorta (Gräser and Rubanyi, 1992),
guinea pig heart (Park et al., 1992), bovine pulmonary artery (Hampl et al.,
1995), pig heart (Xu et al., 1995; Jimenez et al., 1996), human forearm (Blitzer et
al., 1996), dog diaphragm (Ward, 1996), and rat intestine (Bohlen and Nase,
2000; Bohlen and Nase, 2001). Although the exact mechanism by which hypoxia
stimulates NO release from endothelial cells has not been established, some
studies suggest that a reduction in oxygen tension increases intracellular calcium
levels, which promotes both basal and stimulated NO production (Busse et al.,
1993; Hampl et al., 1995; Friebel et al., 1995).
In contrast to the preceding discussion, other investigators have reported
that reduced O2 tension leads to a reduction in NO activity (Hassoun et al., 1994;
Herget et al., 2000; Wood et al., 2000). For instance, Hassoun and coworkers
(1994) reported that exposure of isolated bovine pulmonary artery smooth
muscle cells to hypoxic media enhances the transcription of xanthine
dehydrogenase/xanthine oxidase. In the rat, Wood and colleagues (2000) found
that systemic hypoxia leads to increased reactive oxygen species secondary to
leukocyte activation. Once formed these reactive oxygen species can quickly
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react with and subsequently inactivate NO (Beckman and Koppenol, 1996). For
instance one of these reactive oxygen species, superoxide anion, has been
shown to react with NO to generate peroxynitrite at a rate that is only limited by
its diffusion coefficient (Mateo et al., 2000). Therefore, under hypoxic conditions
it is possible that increased generation of these reactive oxygen species could
limit the bio-availability of NO.
In addition to the effects just described, reduced oxygen tension can
indirectly influence vascular tone by promoting the release of vasoactive factors
such as adenosine and ATP (Forrester and Williams, 1977; Schrader et al. 1977;
Headrick et al., 1992; Raatikainen et al., 1994; Cohen et al., 1995; Ellsworth et
al., 1995; Decking et al., 1997; Dietrich et al., 2000; Ellsworth, 2000; Jagger et
al., 2001). The regulation of vascular tone by these factors will be discussed in
detail in the following sections.

3. Regulation of vascular tone by adenosine and adenine nucleotides.
(a) A Brief History of Purinergic Signaling. The earliest evidence describing
the physiological importance of extracellular adenine compounds was first
reported by Drury and Szent-Györgyi (1929). Thirty years later, Holton (1959)
showed that during antidromic stimulation of sensory nerves, ATP was released
in sufficient quantities to produce vasodilation of rabbit ear arteries. A few years
later, Berne (1963) first suggested that adenosine might be the physiological
regulator of coronary blood flow during reactive hyperemia.

Over the next
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decade, interest peaked with regard to the extracellular signalling mechanisms of
adenosine. By the end of the nineteen-seventies, Burnstock (1978) had provided
a basis for distinguishing the two major types of vascular purinergic receptors.
Burnstock classified the purinergic receptors based on their selectivity for the
various purines, with the P1-purinoceptors selective for adenosine and the P2purinoceptors selective for adenine nucleotides. The P1-purinoceptors were the
first to be subdivided into A1 and A2 subtypes (Van Calker et al., 1979; Londos et
al., 1980), followed by the subdivision of P2-purinoceptors into P2X and P2Y
subtypes (Burnstock and Kennedy, 1985). In the following decade, a number of
additional subtypes were added to the P2-purinoceptor family, including P2U,
P2D, P2Z, and P2T (Dubyak and el-Moatassim, 1993; Harden et al., 1995).
However, with the advent of molecular cloning the need for a new nomenclature
soon arose and the classification just described was replaced by the current
nomenclature that designated all P2-purinoceptors as either P2Y or P2X. The
first P2-purinoceptor to be cloned was a G-protein-coupled receptor isolated from
the chick brain and termed P2Y 1 (Webb et al., 1993). About the same time, a
second

G-protein-coupled

receptor

(P2Y 2)

was

identified

from

mouse

neuroblastoma (Lustig et al., 1993). A year later, the first P2 ligand-gated ion
channel receptors P2X1 and P2X2 cloned from rat vas deferens and rat PC12
cells, respectively (Valera et al., 1994; Brake et al., 1994). For a further review of
P2-purinoceptor

classification

Classification and Signaling”.

please

see

section

(c)

“P2-Purinoceptor
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(b) P1-Purinoceptor Classification and Signaling.

Currently, four P1-

purinoceptors have been cloned, (A1, A2A, A2B, and A3) with selective agonists
and antagonists identified for each subtype except A2B (Fredholm et al., 1994;
Olah and Stiles, 1995; Jacobson and Suzuki, 1996).

As stated above, the

adenosine A1 and A2 receptors were the first subdivisions, made on the basis of
their ability to inhibit or stimulate adenylyl cyclase, respectively (Van Calker et al.,
1979; Londos et al., 1980). There is evidence that these adenosine receptors
may signal via G proteins (Fredholm et al., 2000).
Through activation of G proteins, A1 receptors mediate inhibition of adenylyl
cyclase, activation of several types of potassium channels, inactivation of various
calcium channels, and activation of phospholipases leading to the enhanced
formation of IP3 and arachidonic acid (Freund et al., 1994; Gerwins and
Fredholm 1995; Freissmuth et al., 1991). In some tissues, A1 adenosine receptor
activation has also been shown to stimulate phospholipid turnover and increase
intracellular calcium levels, whereas in others, A1 receptor activation inhibits
phospholipid turnover and decreases intracellular calcium levels (Olah and Stiles,
1995). In contrast to A1 receptors, both A2A and A2B receptors stimulate the
formation of cyclic AMP (Olah, 1997; Pierce et al., 1992), and like A1 receptors,
activation of these receptors promotes mobilization of intracellular calcium
(Offerman and Simon, 1995; Gao et al., 1999; Linden et al., 1999). In vascular
smooth muscle, A2 receptor activation can also influence the activity of ATP-

37

dependent

potassium

channels,

which

may

be

involved

in

mediating

endothelium-independent vasorelaxation (Kleppisch and Nelson, 1995).
(c) P2-Purinoceptor Classification and Signaling. Currently, there are five
recognized members of the P2Y receptor family (P2Y 1, P2Y 2, P2Y 4, P2Y 6, and
P2Y 11) and seven recognized members of the P2X family (P2X1-7) (Di Virgilio et
al., 2001).

These receptors were initially classified on the basis of

pharmacological and functional criteria, with receptors classified as either Gprotein-coupled P2Y receptors or as ion-gated channel P2X receptors
(Abbracchio and Burnstock, 1994). However, as molecular techniques evolved,
so did the classification of these receptors, and the original classification was
replaced by the current system that is based on molecular structure.
P2Y receptors are seven-membrane-spanning proteins, numbering from
328 to 379 amino acids, with a molecular mass of 41 to 53 kd after glycosylation
(Ralevic and Burnstock, 1998).

Typically, signal transduction occurs via the

classical pathways triggered by most seven-membrane-spanning receptors with
activation of phospholipase C and/or stimulation/inhibition of adenylyl cyclase.
However, not all P2Y receptors operate through the same intracellular signal
transduction pathway. For example, P2Y 1 and P2Y 2 are coupled to stimulation of
phospholipase C-β and inhibition of adenylyl cyclase via Gq/11 and GI proteins,
respectively (Ralevic and Burnstock, 1998). P2Y 4 and P2Y 6 seem to only couple
to phosphoinositide breakdown, and P2Y 11 stimulates activation of both the
phosphoinositide and the adenylyl cyclase pathways (Di Virgillio et al., 2001).
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P2X receptors are ATP-gated ion channels that were originally cloned and
characterized in excitable cells (Brake et al., 1994; Valera et al., 1994) and
subsequently shown to be ubiquitous receptors capable of mediating fast
permeability changes to sodium, potassium, and calcium (Di Virgillio et al., 1998;
Soto et al., 1997). P2X receptors range from 379 to 595 amino acids and are
thought to have two transmembrane hydrophobic domains separated by a bulky
extracellular region (Ralevic and Burnstock, 1998; Brake et al., 1994; Valera et
al., 1994). Signal transduction occurs via fast sodium and calcium influx and
potassium efflux, leading to depolarization of the plasma membrane and an
increase in cytosolic calcium concentration.
(d) Formation and Release of Adenosine.

Within the cell, adenosine is

typically formed by one of two pathways (Meghji, 1993). In the first pathway,
adenosine formation proceeds in a manner that is augmented by reduced oxygen
availability with the sequential hydrolysis of ATP è ADP è AMP è adenosine
(Shyrock and Belardinelli, 1997).

The final conversion in this sequence, the

hydrolysis of AMP to adenosine, is catalyzed by the enzyme 5’-nucleotidase,
which is present in two forms, an intracellular cytosolic form and an extracellular
membrane-bound form (Shyrock and Belardinelli, 1997). In the second pathway,
adenosine formation proceeds in a manner that is insensitive to changes in
oxygen

availability,

with

the

sequential

hydrolysis

of

ATP

è

S-

adenosylmethionine è S-adenosylhomocysteine, which in turn is hydrolyzed to
adenosine by S-adenosylhomocysteine hydrolase (Shyrock and Belardinelli,
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1997).

Once formed within the cytosol, adenosine can readily cross the cell

membrane via a nucleoside transporter (Conant and Jarvis, 1994).
Adenosine can also be formed extracellularly by the same enzymatic
conversions described above (Shyrock and Belardinelli, 1997). The enzyme 5’ecto-nucleotidase, which is widespread on the outer surface of vascular smooth
muscle and endothelial cells (Borst and Schrader, 1991; Shyrock and
Belardinelli, 1997), is responsible for the ultimate conversion of adenine
nucleotides to adenosine. The endothelium plays a key role in the uptake and
metabolism of adenosine, but is also a major source of endogenous adenine
nucleotides and adenosine (Kroll et al., 1989).

The release of adenine

nucleotides from the endothelium can be stimulated by a variety of factors,
including β-adrenergic stimulation and hypoxia (Schrader et al. 1977; Borst and
Schrader, 1991; Headrick et al., 1992; Raatikainen et al., 1994; Cohen et al.,
1995; Decking et al., 1997).
(e) The Role of Adenosine in the Regulation of Vascular Tone. As stated
above, numerous investigators have demonstrated that adenosine is released by
tissues under low oxygen conditions (Schrader et al. 1977; Headrick et al., 1992;
Raatikainen et al., 1994; Cohen et al., 1995; Decking et al., 1997). As a result of
this release and adenosine’s vasoactive properties, adenosine is well suited to
play an important role in the metabolic regulation of blood flow. In fact, increases
in vascular conductance during systemic hypoxia can be reduced by 50% by the
adenosine receptor antagonists 8-phenyl theophylline (8-PT) and 8-sulphophenyl
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theophylline (8-SPT) and by adenosine deaminase (Neylon and Marshall, 1991;
Thomas et al., 1994).

Similarly, Simpson and Phillis (1991) found that local

application of adenosine deaminase attenuates hypoxia-induced dilation of rat
pial arterioles.
In addition to its role as a mediator of hypoxic vasodilation, adenosine has
been shown to contribute importantly to other microvascular control mechanisms
including autoregulation and active hyperemia.

In the guinea pig heart,

adenosine levels increase as coronary perfusion pressure is reduced, thereby
maintaining coronary blood flow (Schrader et al., 1977).

In the hamster

cremaster muscle, blockade of local adenosine activity with either adenosine
deaminase or theophylline reduces the level of active hyperemia (Proctor and
Duling, 1982; Proctor, 1984). Later, Proctor (1986) reported that these same
treatments significantly reduced, but did not eliminate, the level of absorptive
hyperemia in the rat intestine. Similarly, other investigators have reported a role
for adenosine in the mediation of active hyperemia in the cat soleus and gracilis
muscle, the dog gracilis muscle, and in the dog heart (Schwartz and McKenzie,
1990; Goonewardene and Karim, 1991; Karim and Goonewardene, 1996).
Adenosine-induced dilation of blood vessels has long been considered to be
mediated by the activation of A2 adenosine receptors present on the vascular
smooth muscle (Abebe, et al., 1994; Dubey et al., 1998). However, a number of
recent studies suggest that adenosine may also promote vasodilation through the
activation of endothelial adenosine receptors (Danialou et al., 1997; Li et al.,
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1998; Hein et al., 1999; Peralta et al., 1999; Bryan and Marshall, 1999a; Bryan
and Marshall, 1999b). For instance, Hein and coworkers (1999) demonstrated
that activation of endothelial A2A adenosine receptors dilates porcine coronary
arterioles through the release of endothelial NO.

Similarly, other groups have

found that activation of endothelial A 2 adenosine receptors stimulates NO
synthesis in human and porcine arterial endothelial cells (Li et al., 1998) and in
the rat liver (Peralta et al., 1999).

However, there appears to be some

heterogeneity among vascular beds in the adenosine receptor subtype involved
in this response.

For example, Danialou and colleagues (1997) found that

activation of both A1 and A 2 adenosine receptors can stimulate arteriolar NO
synthesis

in

the

rat

diaphragm,

although

the

A1

mediated

response

predominates. Similarly, Bryan and Marshall (1999), found that activation of both
A1 and A2 adenosine receptors by systemically administered adenosine causes
NO-dependent increases in rat femoral vascular conductance, but that only the
A1 receptor subtype mediates the increased vascular NO synthesis during
systemic hypoxia. A number of other studies have demonstrated that adenosine
is capable of stimulating endothelial NO synthesis (Li et al., 1995; Davis et al.,
1998; Ishibashi et al., 1998; Hein and Kuo, 1999; Yada et al., 1999; Carpenter et
al., 2000; Konduri and Mital, 2000).
In addition to its direct effect on vascular tone, adenosine can attenuate the
presynaptic release of NE in vessels of the rat heart (Richardt et al., 1989) and
dog heart (Abe et al., 1997), and in the dog pulmonary artery (Tamaoki et al.,
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1997b). However, this does not appear to occur in all vascular beds. Kuan and
Jackson (1988) found that endogenous adenosine does not limit NE release in
the rat mesentery. Taken together, these studies indicate that adenosine can
influence vascular tone by at least two and possibly three different mechanisms,
including a direct effect on vascular smooth muscle, promoting the release of
endothelium-derived NO, and in some cases, by limiting the release of NE from
sympathetic nerve terminals.
(f) The Role of Adenine Nucleotides in the Regulation of Vascular Tone. In
recent years, a new model has been presented in which the erythrocyte, in
addition to its role as an oxygen carrier, is the sensor and effector in the local
regulation of oxygen delivery (Ellsworth, 2000).

This model is based on two

factors: the release of ATP from erythrocytes in response to reduced oxygen
tension (Forrester and Williams, 1977; Ellsworth et al., 1995; Dietrich et al., 2000;
Ellsworth, 2000; Jagger et al., 2001), and the vasoactive properties of ATP. As
stated above, the earliest evidence describing the physiological activities of
extracellular adenine compounds was first reported by Drury and Szent-Györgyi
(1929). Since then, numerous groups have illustrated the vasoactive properties
of ATP. DeMey and Vanhoutte (1981) demonstrated that ATP was capable of
stimulating the production of NO. Ellsworth and colleagues (1995) found that
intraluminal application of ATP induces arteriolar dilations that are conducted
over 100 µm upstream from the application site.

Similarly, McCullough and

coworkers (1997) reported that, in hamster cheek pouch, intraluminal ATP
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application induced NO-dependent arteriolar dilations that were conducted
upstream. Furthermore, extraluminal ATP application resulted in a conducted
vasoconstriction that was enhanced in the presence of L-NAME.

That same

year, You and colleagues (1997) reported that luminal application of ATP and
ADP elicited dose-dependent dilations that were abolished by removal of the
endothelium and by treatment with L-NAME. In rat cerebral arterioles, Janigro
and colleagues (1997) demonstrated that ATP elicits a NO-dependent
vasodilation regardless of the application polarity, although arteriolar responses
were greater when ATP was applied intraluminally. Similarly, studies conducted
by others demonstrate that under certain conditions abluminal application of ATP
produces NO-dependent vasodilation of rat skeletal muscle arterioles (Koller et
al., 1991) and hamster cheek pouch arterioles (Duza et al., 2001).

Taken

together, these results suggest that under most conditions, exogenously-applied
ATP produces vasodilation or vasoconstriction depending upon whether the
application is luminal or abluminal.

The characteristics of each response are

presumably a consequence of the distribution of different purinergic receptors
(Abbracchio and Burnstock, 1994).
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PURPOSE OF THIS DISSERTATION PROJECT
Since the vasoactive effects of O2 were first reported, numerous
investigators have attempted to elucidate the mechanism by which O2 effects
vascular tone.

As previously stated, many studies have demonstrated that

changes in O2 tension alter vascular tone through both direct and indirect
mechanisms.

Of those studies that have demonstrated an indirect effect of

reduced O2 tension on vascular tone, only a few have investigated the
mechanism by which reduced O2 promotes the release of endothelium-derived
vasoactive factors. Some of these studies have reported that the increase in NO
synthesis under low O2 conditions is associated with an increase in [Ca2+]i.
However, the mechanism by which [Ca2+]i and NO synthesis increase remains
unclear. In this dissertation project, I endeavored to explore the possible link
between reduced O2 tension and NO synthesis at the microvascular level in the
absence of any systemic effects. Moreover, the level to which O2 was reduced in
these studies was not some arbitrary value, but rather the normal response of the
tissue to sympathetic nerve stimulation at physiological frequencies.

Study I
Endothelium-derived NO normally attenuates neurogenic constriction of the
arterioles in rat intestine despite a marked reduction in hemodynamic shear,
which is considered the primary stimulus for basal NO release in these vessels.
During neurogenic constriction there is a frequency-dependent fall in arteriolar
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blood flow, which should result in a flow-dependent reduction of arteriolar wall
PO2. The purpose of this first study was to determine if reduced arteriolar wall
PO2 serves as a stimulus for sustained NO synthesis during neurogenic
constriction in the rat intestine.

Study II
Study I demonstrated that reduced O2 tension serves as a stimulus for
endothelial NO synthesis during neurogenic constriction in the rat intestine.
Hypoxia-induced formation of the vasoactive metabolite adenosine has been
demonstrated in a number of vascular beds, and adenosine, at moderately low
concentrations, has been shown to stimulate NO release in some types of
arterioles. Therefore, the purpose of this study was to determine if adenosine
serves as the link between reduced O2 tension and NO synthesis during
neurogenic constriction.

Study III
Study II illustrated that adenosine, through its interaction with endothelial A1
receptors, promotes NO synthesis during neurogenic constriction.

Recent

studies have suggested that erythrocytes release ATP in response to reduced O2
tension, and that the enzymes necessary for the sequential hydrolyzation of ATP
to adenosine are prevalent in and around the microvascular wall. The purpose of
this study was to determine the origin of adenosine production during neurogenic
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constriction. Specifically, we evaluated two possible sources of adenosine: (1)
the extracellular conversion of ATP to adenosine (2) the nearby paired venule.
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Study I: Arteriolar Wall PO2 and Nitric Oxide Release
during Sympathetic Vasoconstriction in the rat intestine
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SUMMARY

Endothelium-derived nitric oxide (NO) attenuates arteriolar constriction in
the rat small intestine during periods of increased sympathetic nerve activity.
This study was undertaken to test the hypothesis that a flow-dependent fall in
arteriolar wall PO2 serves as the stimulus for endothelial NO release under these
conditions.

Sympathetic nerve stimulation at 3-16 Hz induced frequency-

dependent arteriolar constriction, with arteriolar wall PO2 falling from 67±3 to as
low as 41±6 mm Hg. Arteriolar responses to nerve stimulation were enhanced
after inhibition of NO synthase with NG-monomethyl-L-arginine (L-NMMA). Under
a high (20%) O2 superfusate, the fall in wall P O2 was significantly attenuated,
arteriolar constrictions were increased by 57±9 to 66±12%, and these responses
were no longer sensitive to L-NMMA. The high O2 superfusate had no effect on
vascular smooth muscle responsiveness to NO (as judged by arteriolar
responses to sodium nitroprusside) or on arteriolar wall oxidant activity (as
determined by the reduction of tetranitroblue tetrazolium dye).

These results

indicate that a flow-dependent fall in arteriolar wall PO2 may serve as a stimulus
for the release of endothelium-derived NO during periods of increased
sympathetic nerve activity.
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INTRODUCTION
It is well established that the endothelium exerts a considerable local
influence on microvascular tone and blood flow through the release of diffusible
vasoactive factors such as nitric oxide (NO) and various cyclooxygenase
products (15, 30). The release of these factors is governed by the immediate
chemical environment of the endothelial cell (including the binding of various
agents to membrane-bound receptors) and by physical forces acting on the
vessel wall (2, 8, 12). In addition to a direct effect on vascular smooth muscle,
endothelium-derived factors can indirectly influence microvascular tone by
modulating the activity of other microvascular control mechanisms (23, 24, 26).
Studies in rat cremaster muscle and canine epicardium have demonstrated that
arteriolar constriction in response to exogenous norepinephrine (NE) is enhanced
after inhibition of NO synthesis (19, 26).

This laboratory has more recently

reported that endothelium-derived NO normally decreases arteriolar constriction
during periods of increased sympathetic nerve activity in the rat intestine (23, 24).
This arteriolar NO release occurs despite a marked reduction in luminal shear
stress, and does not depend on the binding of neurally-released NE to
endothelial α2 receptors (25).
The sympathetic constriction of resistance vessels is accompanied by a
reduction in local blood flow (3, 4, 23) and a consequent fall in arteriolar wall O2
levels (4). There is mounting evidence that a reduction in vascular wall PO 2 can
promote vasodilation via the release of endothelium-derived NO (1, 10-12, 16,
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21, 22, 27-29, 35). The aim of the current study was to investigate the functional
significance of any relationship between arteriolar wall O2 tension and local NO
activity in the intestine.

More specifically, we tested the hypothesis that a

reduction in arteriolar wall PO2 serves as the stimulus for arteriolar NO production
during periods of increased sympathetic nerve activity.

If this hypothesis is

correct, then minimizing the fall in arteriolar wall PO 2 should diminish the stimulus
for NO release and lead to augmented sympathetic constriction. To test this
prediction, arteriolar responses to sympathetic nerve stimulation were assessed
under normal conditions and under a hyperoxic superfusate (to maintain
arteriolar wall O2 delivery) before and during inhibition of NO synthesis with NGmonomethyl-L-arginine (L-NMMA). Arteriolar wall PO 2 was directly measured
with O2 sensitive microelectrodes to verify the effects of sympathetic nerve
stimulation and increased superfusate O2 content on arteriolar wall O2 levels.

METHODS
All surgical and experimental procedures were approved by the West
Virginia University Animal Care and Use Committee. Male Sprague-Dawley rats
aged 8-9 wk (Harlan Sprague Dawley, Indianapolis, IN) were anesthetized with
sodium thiopental (100 mg/kg ip) and placed on a heating mat to maintain a 37o C
rectal temperature. To ensure adequate gas exchange rats were intubated and
ventilated by a rodent ventilator (Harvard Apparatus, South Natick, MA). Arterial
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pressure was measured directly with a Gould P23 ID pressure transducer
(Cleveland, OH) connected to a cannula inserted into the right carotid artery.
The small intestine was prepared for microscopic observation as previously
described (23).

Briefly, a 14-cm loop of small intestine (ileum) was gently

exteriorized through a midline abdominal incision. The loop was initially bathed
in warm Normosol-R electrolyte solution (Abbott Laboratories, Chicago, IL) and
then continuously superfused with a physiological electrolyte solution (in mM:
119 NaCl, 25 NaHCO 3, 6 KCl, and 3.6 CaCl 2) that was warmed to 37oC and
equilibrated with a gas mixture to either mimic normal in-vivo conditions (5% O25% CO 2-90% N2) (5) or create a hyperoxic environment (20% O2-5% CO 2-75%
N2).

Isoproterenol (10 mg/l; Sigma, St. Louis, MO) and phenytoin (20 mg/l;

Parke-Davis, Morris Plains, NJ) were added to the superfusate to suppress
intestinal motility. At these concentrations neither agent alters resting arteriolar
tone in this vascular bed (9). After the ileum was exteriorized, 2 small incisions 6
cm apart were made by thermal cautery along the antimesenteric border, and
chyme was flushed from the lumen through these incisions. The bowel was then
secured over a transparent pedestal by 4 sutures tied to the antimesenteric
border.

Most of the preparation was covered with polyvinyl film, with the

superfusate flow directed beneath the film. With the normal (5% O2) superfusate,
this arrangement stabilizes solution PO2 above the tissue at 40-50 mmHg (6).
After surgery, the rat was transferred to the stage of an Olympus BHTU
intravital microscope (Hyde Park, NY) fitted with a CCD video camera (Dage
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MTI, Michigan City, IN). Video images were displayed on a Panasonic highresolution video monitor and stored on videotape for off-line analysis.
Observations were made with a x10 eyepiece and Nikon x10 water immersion
objective (final video magnification = x 730).

Arteriolar inner diameters were

measured with a video caliper (Microcirculation Research Institute, Texas A & M
University) during videotape replay.
Arteriolar wall PO2 was measured with Whalen-type O2 microelectrodes (tip
diameter = 2-3 µm, Diamond General, Ann Arbor, MI) that were calibrated
immediately before and after each experiment. Data from electrodes exhibiting
more than a 5% change in gain from pre- to postexperimental calibrations were
discarded. For calibration, electrodes were placed in a tonometer (model 1251,
Diamond General), and current output was recorded in superfusates equilibrated
with 10% and 20% O2 gas mixtures (PO2 = 71 and 142 mm Hg, respectively).
Zero-level P O2 was determined by placing the electrode tip in an actively
respiring yeast mixture as described by Whalen et al (36).
For sympathetic nerve stimulation, a bipolar platinum electrode secured in a
micromanipulator was used to stimulate the sympathetic postganglionic efferents
in the sheath surrounding a mesenteric artery-vein pair upstream from the
arteriole under study.

The electrode and artery-vein pair were briefly raised

above the superfusate and the nerves were stimulated with square-wave pulses
at supramaximal voltage (5-6 V) and a pulse duration of 10 ms.

These

stimulation parameters elicit frequency-dependent arteriolar constrictions that are
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abolished by the non-selective α-receptor antagonist phentolamine (23) and the
selective α1-receptor antagonist prazosin (25), verifying that these responses are
due to sympathetic nerve activation.

Experimental Protocols. The first series of experiments was designed to
define the relationship between arteriolar wall O2 tension and NO during periods
of increased sympathetic nerve activity.

During superfusion with either the

normal (5% O2) or hyperoxic (20% O2) solution, a first-order arteriole was
selected for study and an O2 microelectrode was positioned with the tip in light
contact with the outer vessel wall. After a 1-min control period, the sympathetic
nerves were stimulated for 1 min at 3, 8, or 16 Hz, followed by a 3-min recovery
period.

This sequence was repeated 2 more times so that the arteriole was

subjected to all 3 levels of increased sympathetic nerve activity, delivered in
random order. The superfusate was then changed (from normal to hyperoxic or
from hyperoxic to normal), and the sequence of nerve stimulations was repeated.
The nerve stimulation sequences under both the normal and hyperoxic
superfusates were then repeated during continuous exposure of the vasculature
to the NO synthase (NOS) inhibitor NG-monomethyl-L-arginine (L-NMMA, 1x10-4
M superfusate concentration). Finally, adenosine was added to the superfusate
(10-3 M final concentration), and passive arteriolar diameter was measured.
The second series of experiments was designed to assess L-NMMA’s
efficacy as a NOS inhibitor under our experimental conditions by evaluating its
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effect on first-order arteriolar responses to A23187 (Sigma), a calcium ionophore
that stimulates NO synthesis in various vascular beds (33). A23187 was initially
dissolved in dimethyl sulfoxide (DMSO, Sigma) and then added to the
superfusate. Control measurements verified that DMSO at its final superfusate
concentration (0.2%) had no direct effect on arteriolar tone. Due to a prolonged
vasoactive effect of A23187, it was necessary to conduct these experiments in 2
groups of rats. In the first group, A23187 was applied to the preparation at final
superfusate concentrations of 1x10 -5 M and 2x10 -5 M.

In the second group,

A23187 was applied at these same concentrations in the presence of 10-4 LNMMA.

At the end of each experiment, passive arteriolar diameters were

measured under 10-3 M adenosine.
A third series of experiments was designed to determine if the hyperoxic
superfusate used in this study causes any change in the inherent responsiveness
of arteriolar smooth muscle to NO. First-order arteriolar responses to the NOdonor sodium nitroprusside (SNP, Sigma) were assessed under both the normal
and hyperoxic superfusates. For these experiments, SNP was applied directly to
the arteriolar wall by microiontophoresis. Glass micropipettes (2-3 µm inner tip
diameter) were filled with 0.5 M SNP in distilled water and connected to an
iontophoresis current programmer (model 260, World Precision Instruments,
Sarasota, FL). A retaining current of 40 nA was used to prevent diffusion of SNP
from the pipette tip, and net ejection currents of 5, 20, and 40 nA (in random
order) were used to deliver SNP to the vessel wall. Each vessel was observed
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during a 2-min control period, a 2-min application period, and a 2-min recovery
period. To avoid potential complications related to acute changes in endogenous
NO production, these experiments were conducted in the presence of 10-4 LNMMA. Finally, the passive diameter of each arteriole was measured under 10-3
M adenosine.
A fourth series of experiments was designed to determine if any apparent
change in NO activity under the hyperoxic superfusate could be due to the
unintended generation of reactive O2 species (32). Oxidant activity within the
arteriolar wall was assayed under the normal and hyperoxic superfusates by the
tetranitroblue tetrazolium (TNBT) reduction method, as described by Swei et al
(34). Upon coming into contact with reactive O2 species, TNBT is reduced to
formazan, an insoluble blue/black compound (34). After a 1-hour equilibration
period under either the normal or hyperoxic superfusate, TNBT (Vector
Laboratories, Burlingame, CA) was added to the superfusate (2% final
concentration) and the preparation was continuously exposed to TNBT at the
prevailing superfusate O2 level for 1 hour. The preparation was then rinsed with
the original superfusate, fixed with a 10% formalin solution (Sigma), and excised.
Each whole-muscle specimen was placed on a glass slide and viewed under an
Olympus BHMJ microscope with a Nikon x40 water immersion objective (final
video magnification = x2920). Images were captured and digitized with a frame
grabber and image analysis software (MetaMorph Imaging System 3.5, West
Chester, PA). Using a 4x10 µm video photometric window, a series of average
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gray-value measurements were made along the wall of first-order arterioles. To
quantify arteriolar wall formazan content (an index of oxidative stress), these
measurements were used to calculate wall light absorption (A): A = ln(It/Io), where
It is the arteriolar wall gray value and Io is the gray value for an immediately
adjacent avascular region.

Positive controls for superoxide anion generation

were produced under both the normal and hyperoxic superfusates by continuous
infusion of hypoxanthine (HX, 0.12 mg/min) + xanthine oxidase (XO, 0.15 U/min)
into the carotid artery for 1 hour. HX and XO were obtained from ICN Biomedical
Inc. (Aurora, OH).

Data and Statistical Analysis.

All data are expressed as means ± SE.

Statistical analysis was carried out using commercially available software (Sigma
Stat, Jandel Scientific, San Rafael, CA). ANOVA for repeated measures was
used to compare arteriolar dilations to A23187 and SNP before and after
treatment with L-NMMA or the high-O2 superfusate, respectively. ANOVA for
repeated measures was also used to compare arteriolar constrictions to
sympathetic nerve stimulation before and after L-NMMA under the low and highO2 superfusates, as well as for comparison of arteriolar wall PO2 values under the
high and low-O2 superfusate. For all ANOVA procedures, the Student NewmanKeuls multiple range procedure for post hoc analysis was used to identify
differences among specific groups. Significance was assessed at P < 0.05 for all
statistical tests.
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RESULTS
Eleven Sprague-Dawley rats (274±11 g b.w.) were used in the first series of
experiments to explore the relationship between arteriolar wall O2 tension and
the influence of local NO on arteriolar sympathetic constriction.

Under the

normal superfusate, the first-order arterioles selected for study had a resting
diameter of 63±3 µm and a passive diameter of 88±3 µm.

Sympathetic nerve

stimulation induced frequency-dependent constrictions, with arteriolar diameters
being reduced to 55±3, 48±3, and 41±3 µm during stimulation at 3, 8, and 16 Hz,
respectively (Fig. 1).

In the presence of 10-4 M L-NMMA, resting arteriolar

diameters were unchanged (60±3 µm), but responses to each level of
sympathetic nerve stimulation were significantly enhanced.

During L-NMMA

exposure, stimulation at 3, 8, and 16 Hz reduced arteriolar diameters to 47±2,
40±3, and 35±3 µm, respectively.
Resting arteriolar diameters under the hyperoxic superfusate were similar to
those under the normal superfusate (63±3 µm), but arteriolar responses to
sympathetic nerve stimulation were significantly enhanced under these
conditions (Fig. 2). Stimulation at 3, 8, and 16 Hz elicited steady-state arteriolar
constrictions of 9±2, 15±1, and 21±2 µm from control under the normal
superfusate vs. 15±2, 24±3, and 33±3 µm
from control under the hyperoxic superfusate. As under the normal superfusate,
L-NMMA did not alter resting arteriolar diameters (62±3 µm) under the hyperoxic
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superfusate.

However, in contrast to the normal superfusate, L-NMMA no

longer enhanced arteriolar responses to sympathetic nerve stimulation under the
hyperoxic superfusate (Fig. 3). Stimulation at 3, 8, and 16 Hz reduced arteriolar
diameters to 49±2, 38±2, and 30±2 µm in the absence of L-NMMA vs. 49±2,
40±2, and 33±2 µm in the presence of L-NMMA.
Under the normal superfusate, resting arteriolar wall PO2 averaged 69±6
mm Hg and tended to fall (but not significantly) during sympathetic nerve
stimulation at 3 Hz. However, during nerve stimulation at 8 and 16 Hz, wall PO2
rapidly fell to a new steady-state level that was dependent on stimulation
frequency (Fig. 4). Exposure to the hyperoxic superfusate did not significantly
change resting wall PO2 (78±6 mm Hg), but the fall in wall PO2 during sympathetic
constriction was significantly attenuated under these conditions. Stimulation at 3,
8, and 16 Hz reduced arteriolar wall PO2 to 59±4, 50±5, and 42±5 mm Hg under
the normal superfusate vs. 70±5, 62±5, and 53±5 mm Hg under the hyperoxic
superfusate.

The steady-state wall PO2 values reached during 3 and 8 Hz

stimulation under the hyperoxic superfusate (70±5 and 62±5 mm Hg) were not
significantly different from resting wall PO2 under the normal superfusate.
The effectiveness of L-NMMA as a NOS inhibitor in the rat intestine was
tested in the second series of experiments by evaluating arteriolar responses to
A23187 in 5 rats (259±25 g) and arteriolar responses to A23187 + L-NMMA in 4
rats (247±26 g). Resting and passive arteriolar diameters averaged 73±4 µm
and 109±9 µm, respectively, for the first group (n=10 vessels), and 74±3 µm and
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94+4 µm, respectively, for the second group (n=10 vessels). Figure 5 shows
arteriolar diameter responses to A23187 in these 2 groups. In the first group,
1x10 -5 M and 2x10 -5 M A23187 significantly increased arteriolar diameter to 96±7
m and 105±8 µm, respectively (dilations of 29±3 and 42±5% from control). In
the second group, L-NMMA completely abolished the vasoactive response to
A23187, with steady-state diameters in the presence of either concentration
averaging 72±5 µm, or 4±4% below control. This finding indicates that we were
able to maximally inhibit NO synthesis with L-NMMA in this preparation.
Eight rats (258±18 g) were used in the third series of experiments to
evaluate the effect of the hyperoxic superfusate on vascular smooth muscle
responsiveness to NO. The arterioles studied in these experiments had resting
and passive diameters of 62±1 µm and 106±3 µm, respectively (n=8 vessels).
The steady-state diameters reached during iontophoretic application of SNP at 5,
20, and 40 nA averaged 83±3, 94±3, and 103±4 µm under the normal
superfusate, and were not significantly different from those reached during SNP
application under the hyperoxic superfusate (81±6, 92±5, and 102±5 µm) (Fig. 6).
Twenty rats (287±7 g) were used in the fourth series of experiments to
evaluate oxidative stress in the arteriolar wall under the normal or hyperoxic
superfusates. The calculated light absorption values indicated that there was no
difference in arteriolar wall formazan content (and therefore oxidant activity)
between vessels exposed to TNBT under the normal superfusate (absorption = 4.8±0.9 units) and those exposed to TNBT under the hyperoxic superfusate
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(absorption = -4.7±0.5 units). Following arterial infusion of HX/XO, arteriolar wall
formazan content was significantly increased to the same level under both
superfusates (absorption = -7.9±0.5 units under the normal superfusate and –
7.9±0.4 units under the hyperoxic superfusate), indicating elevated oxidant
activity.
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Figure 1.
First-order arteriole diameter responses to sympathetic nerve
stimulation at 3, 8, and 16 Hz under normal superfusate (closed circles) and
normal superfusate + 10-4 M L-NMMA (open circles). n=11 vessels. *P<0.05 vs.
normal superfusate.

62

0

3 Hz

8 Hz

16 Hz

Change From Control Diameter ( µm)

-5

-10

-15

*
-20

-25

*

-30

-35

-40

Normal Superfusate
20% O Superfusate
2

*

Figure 2. Magnitude of arteriolar constriction (in µm) induced by sympathetic
nerve stimulation at 3, 8, and 16 Hz under normal superfusate (solid bars) and
20% O2 superfusate (hatched bars). n=11 vessels.
*P<0.05 vs. normal
superfusate.
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Figure 3.
First-order arteriole diameter responses to sympathetic nerve
stimulation at 3, 8, and 16 Hz under 20% O2 superfusate (closed circles) and
20% O2 superfusate + 10-4 M L-NMMA (open circles). n=11 vessels.

64

PO2 (mm Hg)

90

* * * * ** * *

80
70
60
50
40
30
90

PO2 (mm Hg)

Stimulation

Normal Superfusate
20% O 2 Superfusate

3Hz

80

* **

70

* ** * * **

60
50
40
30

8Hz

PO2 (mm Hg)

90
80
70

* * ** * *

60
50
40
30

16Hz
0

30

60

90

120

150

180

Time (s)
Figure 4. Arteriolar wall PO2 during sympathetic nerve stimulation at 3, 8, and 16
Hz under normal superfusate (closed circles) and 20% O2 superfusate (open
circles). n=8 vessels. *P<0.05 vs. normal superfusate.
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67

DISCUSSION
A reduction in O2 availability can decrease arteriolar tone through a direct
effect on the vessel wall and/or indirectly via changes in the metabolic state of
nearby parenchymal cells (13, 16, 29). The mechanism(s) by which resistance
vessels are directly sensitive to reduced O2 can vary depending on the vascular
bed.

Harder et al. have reported that reduced O2 levels in rat renal and

cremaster muscle microvessels may lead to reduced formation of 20-HETE, a
constitutively-produced cytochrome p450 metabolite that normally acts as a
potent vasoconstrictor (17). In other cases, a fall in local PO2 leads to increased
release of one or more endothelium-derived vasodilator prostanoids. This has
been demonstrated in vitro for resistance vessels in rat heart (27) and arterioles
isolated from dog heart (22) and rat cremaster muscle (21). In contrast, a fall in
PO2 increases the release of endothelium-derived NO from resistance vessels in
the coronary circulation of the pig (18) and guinea pig (28), the diaphragm of the
dog (35), and in the human forearm vasculature (1). There is also evidence of
O2-sensitive NO release in some vascular beds of the rat. Pries et al (30) have
reported an inverse correlation between elevated microvascular O2 levels and
NO activity in the rat spinotrapezius muscle.

The hypoxia-induced dilation of

preconstricted rat aortic ring segments is also due to the release of endotheliumderived NO (16).
The results of our current study suggest that a reduction in arteriolar wall
PO2 may serve as a major stimulus for arteriolar NO production during
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sympathetic vasoconstriction in the rat intestine.

Resting arteriolar wall P O2

under the normal superfusate averaged 69±6 mm Hg, which is consistent with an
earlier study in the rat intestine by Bohlen and Lash (7), who found that resting
wall PO2 averages 65-70 mm Hg in first-order arterioles and as low as 50 mm Hg
in more distal arterioles, indicating a marked precapillary oxygen loss from these
downstream vessels.
stimulation

produced

Under the normal superfusate, sympathetic nerve
frequency-dependent

arteriolar

constriction

and

a

significant reduction in arteriolar wall PO2 at stimulation frequencies of 8 and 16
Hz (Figs. 1 and 4). At all stimulation frequencies, the magnitude of sympathetic
constriction was significantly increased in the presence of the NOS inhibitor LNMMA (Fig. 1), which is consistent with a previous report by this laboratory in
which this effect of L-NMMA was also completely reversed by excess L-arginine
(23). Although mean arteriolar wall PO2 was not significantly reduced during 3 Hz
nerve stimulation under the normal superfusate (Fig. 4), wall PO2 did fall by an
average of 13±4 mm Hg in 6 of the 8 vessels studied, and in those vessels LNMMA significantly enhanced the sympathetic constriction.

In the remaining 2

vessels where wall PO2 did not fall under these conditions, L-NMMA had no effect
on sympathetic constriction.

These observations strongly suggest that

endogenous NO plays an important role in limiting the magnitude of sympathetic
arteriolar constriction when arteriolar O2 levels fall in this vascular bed. We have
more recently determined that this NO is of endothelial origin, based on the loss
of this NO influence after functional disruption of the endothelium (24).
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In the current study, the high-O2 superfusate that we used did not
significantly increase resting arteriolar wall PO2, but did limit the fall in wall PO2
that accompanies sympathetic nerve stimulation (Fig. 4).

This is most likely

because arteriolar wall O2 levels are predominantly influenced by blood O2
delivery during normal flow conditions, with extraluminal O2 delivery from the
superfusate only becoming an important contributor to wall oxygenation as blood
flow falls (4). Under the O2-enriched superfusate, arteriolar wall PO2 remained at
resting levels throughout the 3 Hz sympathetic nerve stimulation (Fig. 4). Under
these conditions, the magnitude of the sympathetic constriction was increased
and no longer sensitive to L-NMMA (Figs. 2 and 3). Although arteriolar wall PO2
still fell during the 8 and 16 Hz stimulations under the high-O2 superfusate,
sympathetic constriction was also increased and no longer sensitive to L-NMMA.
Based on our hypothesis, we might have expected these decreases in wall PO2
to stimulate NO synthesis and thus make the arteriolar responses to sympathetic
nerve stimulation sensitive to NOS inhibition. However, a closer inspection of the
data reveals that while wall PO2 fell during the 8 Hz stimulation under increased
superfusate O2, the level to which it fell was not below the resting value for these
vessels measured under the normal superfusate (Fig. 4). This suggests that a
fall in wall O2 levels may only promote NO release if PO2 falls below some critical
level. Taken together, the observations for sympathetic nerve stimulation at 3
and 8 Hz suggest a causal link between reduced arteriolar wall PO2 and NO
release during sympathetic constriction. However, the lack of an effect of
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L-NMMA on arteriolar responses to the 16 Hz nerve stimulation under the highO2 superfusate is inconsistent with this interpretation, since the level to which
wall PO2 falls under these conditions is similar to that measured during 8 Hz
stimulation under the normal superfusate (where constriction was enhanced by
L-NMMA). It may be that the dramatic (and possibly maximal) constriction of
these vessels during this supraphysiological level of nerve stimulation in a highO2 environment was so overwhelming that locally-released NO was simply
unable to exert any modulating effect on the response.
In previous efforts to identify the stimulus for arteriolar NO release during
sympathetic constriction in rat intestine, this laboratory ruled out the possibility
that neurally-released norepinephrine was stimulating NO release by binding to
endothelial α2 receptors (25). Another possible stimulus that could act in concert
with reduced arteriolar wall PO2 is hemodynamic shear stress, which serves as
an important trigger for continuous endothelial NO release during periods of
normal and increased luminal flow (2, 8, 15).

However, sympathetic nerve

stimulation at 3, 8 and 16 Hz reduces average wall shear rate in first-order
intestinal arterioles by 20%, 45% and 73%, respectively (25), and Bohlen and
Nase (8) have reported a linear relationship between wall shear rate and
periarteriolar [NO] for these vessels, with each 10% change in shear rate causing
a 6% change in [NO]. If flow-dependent shear stress remained the predominant
stimulus for endothelial NO release in these arterioles during sympathetic
constriction, then Bohlen and Nase’s calculations would predict a reduction in NO
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release of 12% during 3 Hz stimulation, 23% during 8 Hz stimulation, and 37%
during 16 Hz stimulation.

Because arteriolar NO release appears to be well

maintained throughout sympathetic nerve stimulation (Fig. 1; Refs. 23, 24), it
appears unlikely that shear stress remains the primary stimulus for NO release
under these conditions.
Instead of reflecting suppressed NO release, the enhanced sympathetic
constriction and its resistance to L-NMMA under the hyperoxic superfusate could
have been due to a reduction in arteriolar smooth muscle responsiveness to NO.
However, our finding that arteriolar responses to the NO donor SNP were
unchanged under the hyperoxic superfusate (Fig. 6) argues against this
possibility. Alternatively, the apparent absence of arteriolar NO activity under the
hyperoxic superfusate could have been due to accelerated NO breakdown by
reactive oxygen species generated in the arteriolar wall (32). Although our direct
measurements indicate that resting arteriolar wall PO2 was not significantly
increased during exposure to the hyperoxic superfusate, there was a clear trend
toward higher resting wall P O2 under these conditions (Fig. 4). We therefore
used the TNBT reduction method to assess arteriolar oxidant activity in
preparations exposed to either the normal or hyperoxic superfusate.

This

method has been previously used to demonstrate increased oxidative stress in
arteriolar and venular walls of hypertensive Dahl rats (34) and normotensive rats
fed a high salt diet (20).

In the current study, exposure to the hyperoxic

superfusate had no effect on arteriolar wall light absorption following TNBT
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exposure, arguing against increased oxidant activity in these vessels. Exposure
to intravascular HX/XO changed arteriolar wall light absorption by the same
amount under the normal superfusate and the hyperoxic superfusate (64-68%),
indicating that the sensitivity of the TNBT reduction method is sufficient to detect
increased oxidative stress under either superfusate.
The lack of an effect of L-NMMA on resting arteriolar tone in the intestine
(Figs. 1 and 5) contrasts with findings in other vascular beds (2, 15, 26, 30), but
is consistent with our previous findings in this preparation (24). In light of recent
direct measurements verifying that NO is continuously released from these
vessels in the resting state (8), local NOS inhibition would be expected to reduce
arteriolar diameter.

However, resting arteriolar tone is the result of vascular

smooth muscle’s integration of numerous simultaneous vasoactive signals, and
the activity of local metabolic and myogenic control mechanisms may set
vascular tone at some constant and optimal level for the tissue. These local
regulatory mechanisms may be so highly developed in the intestine that the
withdrawal of any single influence (such as NO in the presence of L-NMMA) is
accompanied by a compensatory change in the activity of one or both of these
systems, thereby preserving the level of tone. The lack of effect of increased
superfusate O2 on resting arteriolar tone (Fig. 6), which also contrasts with
findings in some other vascular beds (3, 4, 13, 30), could simply reflect the fact
that the level of O2 in the superfusate was insufficient to significantly alter resting
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arteriolar wall PO2 (Fig. 4). Therefore, a direct effect of oxygen on the vessel wall
would be unlikely under these conditions.
Since molecular O2 serves as a co-substrate for all isoforms of NOS (14,
37), one might expect a fall in arteriolar wall PO2 to limit arteriolar NO production
instead of increasing it. This would undoubtedly be the case if the endothelial
cell O2 concentration reached rate-limiting levels, but during our experiments
arteriolar wall PO2 never fell to the level corresponding to the Km of O2 for either
isolated eNOS (6 mm Hg) (31) or eNOS in intact endothelial cells (38 mm Hg)
(37).

Therefore, we conclude that the reduction in arteriolar wall P O2 during

sympathetic constriction was probably not sufficient to limit endothelial NO
synthesis in the current study. Our observations suggest that as arteriolar wall
PO2 falls, NO synthesis may in fact change in a biphasic manner. A fall in PO2
from resting levels could initially stimulate NO synthesis, whereas a continued fall
to lower levels would begin to suppress NO synthesis as O2 becomes limited as
a NOS co-substrate. The mechanism by which reduced arteriolar wall O2 tension
could lead to increased NO synthesis has not been clearly established. Some
investigators have reported that a fall in O2 tension increases cytosolic Ca+2
levels in endothelial cells, which would increase both basal and stimulated NO
production (12, 15). Alternatively, Bryan and Marshall (10, 11) have suggested
that a reduction in blood P O2 can promote the release of adenosine from the
endothelium of resistance vessels, and that this adenosine acts in an autocrine
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fashion to hyperpolarize the endothelial cell membrane via activation of receptorcoupled KA TP channels.
In summary, we have shown that if the fall in arteriolar wall PO2 associated
with neurogenic constriction is limited by increased superfusate O2 delivery,
sympathetic neurogenic vasoconstriction is enhanced and no longer sensitive to
NOS inhibition. This effect can not be explained by reduced vascular smooth
muscle responsiveness to NO or by oxidative degradation of NO. These results
suggest that during periods of increased sympathetic nerve activity, a flowdependent fall in arteriolar wall PO2 may serve as a stimulus for the release of
endothelial NO that in turn limits arteriolar neurogenic constriction.
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Study II: Reduced PO2 and adenosine formation preserve
arteriolar nitric oxide synthesis during sympathetic
constriction in the rat intestine
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SUMMARY
Previous reports by this laboratory have indicated that a flow-dependent fall
in arteriolar wall PO2 may be a stimulus for the sustained release of endothelial
nitric oxide (NO) during sympathetic vasoconstriction in the superfused rat
intestine. In this study, we tested the hypothesis that locally-formed adenosine
serves as the link between the fall in local PO2 and NO synthesis under these
conditions.

Adenosine applied via pressurized micropipettes directly onto the

wall or at a distance of 25 µm from the wall of first-order arterioles (resting
diameter = 54±1 µm) elicited dose-dependent dilations of 15-46% that were
significantly reduced by the NO synthase inhibitor NG-monomethyl-L-arginine (LNMMA, 10-4 M). Arteriolar responses to sympathetic nerve stimulation were
enhanced by 57-66% in the presence of L-NMMA or when tissue P O2 was
prevented from falling under a high O2 superfusate. Adenosine deaminase (2.0
U/ml) or the selective A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine
(4x10-4 M) completely blocked the enhancing effect of L-NMMA on sympathetic
constriction. These results are consistent with the hypothesis that the fall in
arteriolar wall and/or tissue P O2 that accompanies sympathetic arteriolar
constriction in the rat intestine can lead to local adenosine production, which in
turn preserves endothelial NO release.
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INTRODUCTION
Previous studies by this laboratory have demonstrated that endotheliumderived nitric oxide (NO) normally limits arteriolar responses to increased
sympathetic nerve activity in the intestine [1, 2]. Hemodynamic shear stress and
activation of endothelial α2-adrenoceptors have been ruled out as stimuli for NO
release under these conditions [3]. In contrast, we have recently reported that
the limiting influence of NO on sympathetic constriction is lost when the flowdependent fall in arteriolar wall PO2 is minimized under a hyperoxic superfusate,
implicating reduced local oxygen levels as a possible stimulus for endothelial NO
release [4].
Some investigators have reported that the vascular endothelium itself is
sensitive to local oxygen levels, and that reduced PO2 directly increases the
release of endothelial NO [5-7]. Alternatively, a local decrease in oxygen tension
may indirectly stimulate NO release through adenosine formation.

It is well

established that reductions in oxygen tension lead to increased adenosine levels
[8-10], and adenosine has been shown to stimulate NO synthesis in some
vascular beds [11, 12].

In this study, we tested the hypothesis that locally-

produced adenosine serves as the link between reduced local oxygen levels and
arteriolar NO synthesis during sympathetic constriction in the rat intestine. We
evaluated the effects of NO synthase (NOS) inhibition, enhanced tissue oxygen
delivery, and pharmacological manipulation of adenosine activity on arteriolar
responses to sympathetic nerve stimulation. Nitric oxide synthesis was inhibited
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with the NOS inhibitor NG-monomethyl-L-arginine (L-NMMA), and local oxygen
delivery was enhanced with a hyperoxic superfusate to maintain tissue oxygen
tension at resting levels during sympathetic constriction. Endogenous adenosine
activity was manipulated with adenosine deaminase or the A1 receptor antagonist
8-cyclopentyl-1,3-dipropylxanthine (DPCPX). Tissue PO2 was directly measured
with oxygen sensitive microelectrodes to verify the effects of sympathetic nerve
stimulation and increased superfusate oxygen content on local oxygen levels.

METHODS
All surgical and experimental procedures were approved by the West
Virginia University Animal Care and Use Committee. Male Sprague-Dawley rats
aged 8-9 wk (Harlan Sprague Dawley, Indianapolis, IN) were anesthetized with
sodium thiopental (100 mg/kg ip) and placed on a heating mat to maintain a 37o C
rectal temperature. To ensure adequate gas exchange, rats were intubated and
ventilated by a rodent ventilator (Harvard Apparatus, South Natick, MA). Arterial
pressure was measured directly with a Gould P23 ID pressure transducer
(Cleveland, OH) connected to a cannula inserted into the right carotid artery.
The small intestine was prepared for microscopic observation as previously
described [1], and continuously superfused with a physiological electrolyte
solution (in mM: 119 NaCl, 25 NaHCO 3, 6 KCl, and 3.6 CaCl 2) that was warmed
to 37oC and equilibrated with 5% O2-5% CO 2-90% N2 to mimic normal in-vivo
conditions [13] or 20% O2-5% CO 2-75% N2 to create a hyperoxic environment.
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Isoproterenol (10 mg/l; Sigma, St. Louis, MO) and phenytoin (20 mg/l; ParkeDavis, Morris Plains, NJ) were added to the superfusate to suppress intestinal
motility. At these concentrations, neither agent alters resting arteriolar tone in
this vascular bed [14]. With most of the preparation covered by polyvinyl film, and
superfusate flow directed beneath the film, solution P O2 above the tissue is
maintained at 40-50 mmHg under normal conditions [15].
After surgery, the rat was transferred to the stage of an Olympus BHTU
intravital microscope (Hyde Park, NY) fitted with a CCD video camera (Dage
MTI, Michigan City, IN). Video images were displayed on a Panasonic highresolution video monitor and stored on videotape for off-line analysis.
Observations were made with a x10 eyepiece and Nikon x10 water immersion
objective (final video magnification = x 730). The theoretical resolution of this
system is 1-1.5 µm, with the actual resolution under experimental conditions
slightly diminished due to light scattering by the tissue. Arteriolar inner diameters
were measured with a video caliper (Microcirculation Research Institute, Texas A
& M University) during videotape replay.
Tissue P O2 was measured with Whalen-type O2 microelectrodes (tip
diameter = 2-3 µm, Diamond General, Ann Arbor, MI) that were calibrated
immediately before and after each experiment. Data from electrodes exhibiting
more than a 5% change in gain from pre- to postexperimental calibrations were
discarded. For calibration, electrodes were placed in a tonometer (model 1251,
Diamond General), and current output was recorded in superfusates equilibrated
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with 10% and 20% O2 gas mixtures (PO2 = 71 and 142 mm Hg, respectively).
Zero-level P O2 was determined by placing the electrode tip in an actively
respiring yeast mixture as described by Whalen et al [16].
A bipolar platinum electrode was used to stimulate the sympathetic
postganglionic efferents running along a mesenteric artery-vein pair upstream
from the arteriole under study. The electrode and artery-vein pair were briefly
raised above the superfusate, and the nerves were stimulated with square-wave
pulses at supramaximal voltage (5-6 V) and a pulse duration of 10 ms. These
stimulation parameters elicit frequency-dependent arteriolar constrictions that are
abolished by the non-selective α-receptor antagonist phentolamine [1] and the
selective α1-receptor antagonist prazosin [3], verifying that these responses are
due to sympathetic nerve activation.

Experimental Protocols. In the first series of experiments, we assessed
adenosine’s ability to stimulate arteriolar NO synthesis in this preparation.

A

Picospritzer II pressure ejection system (General Valve, Fairfield, NJ) was used
to eject adenosine from glass micropipettes positioned at the vessel wall or 25
and 50 µm away from the wall. The micropipettes (2-3 µm inner tip diameter)
were filled with 4.7x10-7 M adenosine in superfusion solution.

After a 1-min

control period, adenosine was applied using an ejection pressure of 10, 20, or 30
psi for 1 min. Following a 3-min recovery, this sequence was repeated two more
times so that the arteriole was challenged with all 3 levels of adenosine,
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delivered in random order.

These applications were then repeated during

continuous exposure of the vasculature to the NOS inhibitor L-NMMA at a
superfusate concentration of 1x10 -4 M.
The second series of experiments was designed to define the relationship
between tissue oxygenation and NO activity during periods of increased
sympathetic nerve activity. During superfusion with either the normal (5% O2) or
hyperoxic (20% O2) solution, a single first-order arteriole was selected for study
and an O2 microelectrode was positioned with the tip at the same tissue depth as
the arteriole and 25 µm from the vessel wall. A site 25 µm from the wall was
chosen because the results of our first series of experiments indicated that
adenosine released from distances within 25 µm of the arteriolar wall elicited
dilations that were due largely to NO release (see Fig. 1). After a 1-min control
period, the sympathetic nerves were stimulated for 1 min at either 3 or 8 Hz,
followed by a 3-min recovery period.

This sequence was then repeated for

stimulation at the other frequency so that the arteriole was subjected to both
levels of increased sympathetic nerve activity, delivered in random order. The
superfusate was then changed (from normal to hyperoxic or from hyperoxic to
normal), and the sequence of nerve stimulations was repeated.

The nerve

stimulation sequences under both the normal and hyperoxic superfusates were
then repeated in the presence of 10-4 M L-NMMA.
A third series of experiments was designed to determine if locally-produced
adenosine acting on microvascular A1 receptors could serve as the link between
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the fall in local PO2 and NO synthesis during periods of increased sympathetic
nerve activity.

Experiments were performed on two groups of rats, with the

protocol identical to that used in the second series of experiments except that in
the first group, the vasculature was continuously exposed to 2.0 U/ml adenosine
deaminase (Sigma) and in the second group, the vasculature was continuously
exposed to the selective A1 receptor antagonist DPCPX (4x10-4 M, Sigma). In
pilot experiments, 2.0 U/ml adenosine deaminase maximally reduced arteriolar
responses to 10-3 M adenosine (dilations reduced by 88+13 %). Both adenosine
deaminase and DPCPX were added directly to the superfusate via syringe pump.
DPCPX was initially dissolved in 50% DMSO/50% 0.1 M NaOH.

Control

measurements verified that DMSO at its final superfusate concentration (1.3%)
had no direct effect on arteriolar tone.
In a fourth series of experiments, we evaluated the effectiveness of DPCPX
in blocking arteriolar responses to adenosine. Adenosine was applied directly to
the arteriolar wall via pressurized micropipettes as described above. After a 1min control period, adenosine was applied for 1 min at ejection pressures of 10,
20, and 30 psi (in random order). Each application was followed by a 3-min
recovery period. These applications were then repeated in the presence of 4x
10-4 M DPCPX.
In a fifth series of experiments, the specificity of DPCPX for A1 receptors
was assessed by evaluating its effect on arteriolar responses to the selective A1
agonist

2-chloro-N6-cylclopentyl-adenosine

(CCPA).

CCPA

was

initially
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dissolved in DMSO (0.3% final bath concentration) and then added to the
superfusate at concentrations of 10-7 and 10-6 M (random application order, 7-min
recovery period between applications).
A sixth series of experiments was designed to determine if treatment with
either adenosine deaminase or DPCPX alters the inherent responsiveness of
arteriolar smooth muscle to NO. Arteriolar responses to the NO-donor sodium
nitroprusside (SNP, Sigma) were assessed before and then during exposure to
each agent. Glass micropipettes were filled with 0.5 M SNP in distilled water and
connected to an iontophoresis current programmer (model 260, World Precision
Instruments, Sarasota, FL). A retaining current of 40 nA was used to prevent
diffusion of SNP from the pipette tip, and net ejection currents of 5, 20, and 40 nA
(in random order) were used to deliver SNP to the vessel wall. Each vessel was
observed during a 2-min control period, a 2-min application period, and a 2-min
recovery period. To avoid potential complications related to acute changes in
endogenous NO production, these experiments were conducted in the presence
of 10-4 M L-NMMA.
At the end of all experiments, adenosine was added to the superfusate (10-3
M final concentration), and passive arteriolar diameter was measured.

Data and Statistical Analysis. For each arteriole, the level of resting tone
(T) was calculated as follows: T=[(Dmax -Dc/Dmax ]x100 where Dmax is passive
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diameter under adenosine, and Dc is the diameter measured during the control
period.
All data are expressed as means ± SE. Statistical analysis was carried out
using commercially available software (Sigma Stat, Jandel Scientific, San Rafael,
CA). ANOVA for repeated measures was used to compare arteriolar dilations to
adenosine, CCPA, and SNP before and after treatment with L-NMMA, DPCPX,
or adenosine deaminase.

ANOVA for repeated measures was also used to

compare arteriolar constrictions to sympathetic nerve stimulation before and after
L-NMMA under the low and high-O2 superfusates in the presence and absence
of DPCPX and adenosine deaminase, as well as for comparison of tissue PO2
values under the high and low-O2 superfusate. For all ANOVA procedures, the
Student Newman-Keuls multiple range procedure for post hoc analysis was used
to identify differences among specific groups. Significance was assessed at P <
0.05 for all statistical tests.

RESULTS
In all protocols combined, a total of 78 first-order arterioles were observed in
47 rats. The rats averaged 273±4 g in body weight at 57±1 days of age, with a
mean arterial pressure under anesthesia of 98±1 mm Hg. Arteriolar resting and
passive diameters averaged 54±1 and 87±1 µm, respectively, with an average
calculated arteriolar tone of 37±1%.
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Twenty-six first-order arterioles were studied to evaluate adenosine’s ability
to stimulate arteriolar NO synthesis in this preparation. Although L-NMMA had
no significant effect on resting arteriolar diameters (50±2 µm under control
conditions vs. 52±1 µm during L-NMMA exposure), arteriolar responses to
directly applied adenosine were significantly inhibited by L-NMMA. Adenosine
applied to the arteriolar wall at micropipette ejection pressures of 10, 20 and 30
psi caused dilations of 7±1, 11±1, and 15±2 µm under control conditions
(average dilations of 14, 22, and 30% above resting diameter), vs. 1±1, 3±1, and
3±1 µm in the presence of L-NMMA (dilations of 2, 6, and 6% above resting
diameter) (Fig. 1, top panel). When adenosine was applied to a tissue site 25 µm
from the vascular wall, arteriolar responses to adenosine were still sensitive to
NOS inhibition, with respective dilations of 8±1, 14±1, and 22±3 µm under control
conditions (16, 28, and 44% above resting diameter) vs. 0.3±0.3, 5±2, and 6±1
µm in the presence of L-NMMA (1, 10, and 12% above resting diameter) (Fig. 1,
middle panel). However, when adenosine was applied to a site 50 µm from the
vascular wall, the arteriolar responses were no longer sensitive to L-NMMA
(dilations of 9±2, 14±2, and 21±3 µm, or 18, 28, and 42% above resting diameter
vs. 9±3, 12±3 and 18±1 µm, or 18, 24, and 35% above resting diameter in the
presence of L-NMMA) (Fig.1, bottom panel).
Ten first-order arterioles were studied to define the relationship between
tissue oxygenation and NO activity during periods of increased sympathetic
nerve activity. Under the normal superfusate, sympathetic nerve stimulation
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induced frequency-dependent constrictions, with arteriolar diameters reduced
from 62±1 µm at rest to 50±1 and 44±1 µm (average diameter reductions of 19
and 29%) during stimulation at 3 and 8 Hz, respectively (Fig. 2). In the presence
of L-NMMA, resting arteriolar diameters were unchanged (63±2 µm), but
responses to each level of sympathetic nerve stimulation were significantly
enhanced.

During L-NMMA exposure, stimulation at 3 and 8 Hz reduced

arteriolar diameters to 41±1 and 30±1 µm (average diameter reductions of 35
and 52%), respectively.
Figure 3 illustrates the effect of L-NMMA on steady-state arteriolar
responses to sympathetic nerve stimulation under the normal and high-oxygen
superfusates. As stated above, exposure to L-NMMA significantly enhanced the
maximal arteriolar constrictions under the normal superfusate by 48 to 83% (an
increase in constriction magnitude from 12±1 to 22±1 µm for 3 Hz stimulation,
and from 21±1 to 31±2 µm for 8 Hz stimulation).

Under the high-oxygen

superfusate, resting arteriolar diameters were unchanged (63±2 µm), but control
responses to nerve stimulation were significantly greater than those under the
normal superfusate (constrictions of 22±1 µm, or 35% from resting diameter, at 3
Hz and 31±2 µm, or 49% from resting diameter, at 8 Hz). L-NMMA did not alter
resting arteriolar diameters (61±1 µm) under the high-oxygen superfusate.
However, in contrast to the normal superfusate, L-NMMA did not enhance
arteriolar responses to sympathetic nerve stimulation under the high-oxygen
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superfusate (constrictions of 21±1 µm, or 33% from resting diameter, at 3 Hz and
33±2 µm, or 52% from resting diameter, at 8 Hz).
Under the normal superfusate, resting tissue PO2 measured 25 µm from the
arteriolar wall averaged 41±1 mm Hg (Fig. 4).

During sympathetic nerve

stimulation at 3 Hz, tissue PO2 fell by 32% to 28±3 mm Hg, and at 8 Hz, tissue
PO2 fell by 46% to 22±2 mm Hg. Under the high-oxygen superfusate, resting
tissue P O2 was not significantly changed (44±1 mm Hg), but there was no
significant fall in tissue PO2 during sympathetic constriction. During 3 and 8 Hz
stimulation, steady-state PO2 averaged 41±1 mm Hg and 40±1 mm Hg,
respectively.
Fifteen first-order arterioles were studied to evaluate the contribution of
locally-produced adenosine and microvascular A1 receptors to NO synthesis
during periods of increased sympathetic nerve activity.

Similar to the results

described above, exposure to L-NMMA did not alter the resting tone of the
arterioles observed during this protocol (resting diameter = 56±2 µm under
control conditions and in the presence of L-NMMA). However, in contrast to the
above results, in the presence of adenosine deaminase, arteriolar responses to
sympathetic nerve stimulation were not enhanced by L-NMMA under either the
normal or high-oxygen superfusate (Fig. 5). Under the normal superfusate, 3
and 8 Hz stimulation induced arteriolar constrictions of 15±1 and 31±2 µm (27
and 55% from resting diameter) under control conditions vs. 15±1 and 24±2 µm
(27 and 43% from resting diameter) in the presence of L-NMMA.

Under the
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high-oxygen superfusate, 3 and 8 Hz stimulation induced arteriolar constrictions
of 14±1 and 27±3 µm (28 and 48% from resting diameter) under control
conditions vs. 14±1 and 22±2 µm (28 and 39% from resting diameter) in the
presence of L-NMMA. Similarly, in the presence of DPCPX, arteriolar responses
to sympathetic nerve stimulation were not enhanced by L-NMMA under either
superfusate (Fig. 6).

Under the normal superfusate, 3 and 8 Hz stimulation

induced arteriolar constrictions of 8±1 and 21±3 µm (14 and 38% from resting
diameter) under control conditions vs. 9±1 and 20±2 µm (16 and 36% from
resting diameter) in the presence of L-NMMA.

Under the high-oxygen

superfusate, 3 and 8 Hz stimulation induced arteriolar constrictions of 8±1 and
23±2 µm (14 and 41% from resting diameter) under control conditions vs. 9±1
and 20±2 µm (16 and 36% from resting diameter) in the presence of L-NMMA.
The ability of DPCPX to block arteriolar responses to adenosine was
verified in seven first-order arterioles. The A1 receptor antagonist DPCPX had no
significant effect on the resting diameter of arterioles studied in these
experiments (51±5 µm under control conditions vs. 54±5 µm during DPCPX
exposure). As shown in Figure 7 (top panel), arteriolar responses to adenosine
were virtually abolished in the presence of DPCPX, with application of adenosine
at 10, 20, and 30 psi inducing dilations of 9±2, 13±3, and 18±1 µm (18, 25, and
35% above resting diameter) under control conditions and 0, 1±1, and 1±1 µm (0,
2, and 2% above resting diameter) in the presence of DPCPX.
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The specificity of DPCPX for A1 receptors was evaluated in six arterioles.
Similar to the preceding protocol, the A1 receptor antagonist DPCPX had no
significant effect on the resting diameter of arterioles studied in these
experiments (49±2 µm under control conditions vs. 51±2 µm during DPCPX
exposure). As shown in Figure 7 (bottom panel), the arteriolar dilations induced
by the A1 receptor agonist CCPA at concentrations of 10-7 and 10 -6 M were
significantly reduced in the presence of DPCPX (dilations of 14±2 and 23±2 µm,
or 29 and 47%, under control conditions vs. dilations of 2±1 and 7±1 µm, or 4
and 14%, in the presence of DPCPX).
Fourteen first-order arterioles were studied to evaluate the effect of
adenosine deaminase and DPCPX on vascular smooth muscle responsiveness
to NO. Similar to the above protocols, neither adenosine deaminase nor DPCPX
altered the resting diameter of the arterioles observed in these experiments
(resting diameter of 57±2 µm under control conditions, 59±2 µm in the presence
of adenosine deaminase, and 56±2 µm in the presence of DPCPX). Application
of SNP resulted in dilations that were not significantly altered by either adenosine
deaminase or DPCPX (Fig. 9). For the adenosine deaminase experiments, SNP
applied with ejection currents of 5, 20, and 40 nA induced respective dilations of
10±2, 19±2, and 31±2 µm (18, 33, and 54% above resting diameter) under
control conditions and 12±2, 22±2, and 26±4 µm (20, 37, and 44% above resting
diameter) during exposure to adenosine deaminase.

For the DPCPX

experiments, application of SNP induced dilations of 11±2, 20±2, and 30±3 µm
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(19, 35, and 53% above resting diameter) under control conditions and 12±2,
22±2, and 31±2 µm (21, 39, and 55% above resting diameter) during DPCPX
exposure.
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Figure 1. Arteriolar diameter responses to adenosine applied via pressurized
micropipette directly to the arteriolar wall (top panel), 25 µm from the wall (middle
panel), and 50 µm from the wall (bottom panel) under the normal superfusate,
before (closed bars) and then during (open bars) exposure to 10-4 M L-NMMA. n
= number of vessels. *P<0.05 vs. control.
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during (open circles) exposure to 10-4 M L-NMMA. All data are paired. n = 10
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superfusate (right panel). All data are paired. n = 10 vessels. *P<0.05 vs.
control response to 3 Hz stimulation under normal superfusate; †P<0.05 vs.
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panel). All data are paired. n = 9 vessels.
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panels; crosshatched bars) exposure to 4 x 10-4 M DPCPX. n = number of
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DISCUSSION
Our finding that NOS inhibition greatly enhanced arteriolar responses to
sympathetic nerve stimulation (Fig. 2) is consistent with our earlier reports that
endothelium-derived NO normally limits arteriolar responses to increased
sympathetic nerve activity in the rat intestine [1, 2, 4]. We have recently reported
that a flow-dependent fall in arteriolar wall PO2 may be an important stimulus for
sustained endothelial NO synthesis under these conditions [4], but that study did
not allow us to determine if a reduction in local tissue PO2 could also contribute to
this process. In the current study, sympathetic constriction caused a fall in tissue
PO2 that was greater than the recently reported fall in arteriolar wall PO2

[4].

Furthermore, the limiting influence of NO on sympathetic constriction was lost
when tissue PO2 was prevented from falling during sympathetic nerve stimulation
(Figs. 3 and 4), or when local adenosine activity was abolished via accelerated
adenosine metabolism (Fig. 5) or blockade of microvascular A1 receptors (Fig. 6).
Furthermore, abolition of adenosine activity had no effect on sympathetic
constriction when tissue PO 2 did not fall during sympathetic constriction. It is
unlikely that any of our experimental manipulations simply changed vascular
smooth muscle responsiveness to NO because arteriolar responses to the NO
donor SNP were unaltered by either adenosine deaminase or DPCPX (Fig. 8),
and we have previously shown that exposure to the hyperoxic superfusate also
does not alter arteriolar responsiveness to SNP [4].

Based on our direct

assessments of arteriolar wall oxidant activity [4] it is also unlikely that the
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absence of arteriolar NO activity under the hyperoxic superfusate is due to
accelerated NO breakdown by locally-generated reactive oxygen species. The
current results, in combination with these previous findings, suggest that locallyformed adenosine serves as the link between reduced local oxygen tension and
NO synthesis during neurogenic constriction in the rat intestine.
Our results also suggest that endothelial A1 receptors mediate adenosineinduced NO synthesis in rat intestinal arterioles (Fig. 7). Similarly, Danialou et al.
[17] reported that whereas activation of both A1 and A2 adenosine receptors can
stimulate arteriolar NO synthesis in the rat diaphragm, A1-mediated responses
are predominant. More recently, Bryan and Marshall [5] reported that activation
of both A1 and A 2 receptors by systemically-administered adenosine increases
rat femoral vascular conductance through a NO-dependent mechanism, but only
the A1 receptor subtype mediates increased vascular NO synthesis during
systemic hypoxia.

However, there appears to be some heterogeneity among

vascular beds in the adenosine receptor subtype that mediates this effect. For
example, adenosine induces NO synthesis through the activation of endothelial
A2 receptors in the rat liver [12] and porcine coronary microvessels [11].
In addition to stimulating NO synthesis, adenosine could theoretically limit
sympathetic constriction by presynaptic inhibition of norepinephrine (NE) release,
as has been demonstrated in some canine vascular beds [18, 19].

However,

endogenous adenosine does not decrease NE release in the rat mesentery [20],
and although we did not directly evaluate this possibility in the current study, our
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results suggest that local adenosine also does not limit NE release in the rat
intestine either. If adenosine were inhibiting NE release in addition to stimulating
NO synthesis, then the magnitude of sympathetic constriction during exposure to
adenosine deaminase (Fig. 5) should have been greater than that during
exposure to L-NMMA (Fig. 2). Instead, arteriolar constriction in the presence of
adenosine deaminase (15±1 and 31±2 µm at 3 and 8 Hz, respectively) was not
significantly greater than that in the presence of L-NMMA (22±1 and 31±2 µm at
3 and 8 Hz, respectively). Although these data were obtained in different groups
of rats, resting arteriolar tone and diameter were similar in these groups.
This study did not permit us to determine the exact origin of the adenosine
that links the fall in local PO2 to endothelial NO release. However, based on LNMMA’s effect on arteriolar responses to exogenous adenosine (Fig. 1), we
conclude that the adenosine involved in stimulating NO release must come from
sites less than 50 µm from the vessel wall.

Although arteriolar responses to

adenosine applied 50 µm from the wall were not dependent on NO synthesis, an
interpolation of our findings suggests that NO becomes increasingly more
important in this response as adenosine is released from closer sites, until it
mediates nearly all of the response to adenosine released within 25 µm of the
wall. This “gradient” in the involvement of NO may reflect the existence of 2
different receptor subtypes in the arteriolar wall with different affinities for
adenosine. Bryan and Marshall [5] have recently reported that in rat hindlimb
resistance vessels, high-affinity A1 receptors are primarily located on the
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endothelium whereas low-affinity A2 receptors predominate on the vascular
smooth muscle. In this case, if adenosine is applied at relatively low doses in
close proximity to the arteriolar wall (e.g., within 25 µm), the action of A1
receptors would be expected to prevail and a largely NO-dependent response
should occur.

Responses to adenosine released 50 µm from the wall may

induce a NO-independent dilation (i.e., a direct effect on smooth muscle) simply
because adenosine is not reaching the endothelium in sufficient quantities to
stimulate NO synthesis.
We have recently reported that arteriolar wall PO2 declines by 14-28 %
during 3-8 Hz sympathetic nerve stimulation in this vascular bed [4]. As in the
current study, arteriolar responses to nerve stimulation were enhanced and no
longer sensitive to L-NMMA when we used a high-oxygen superfusate to limit
this fall in PO2 [4], suggesting that the arteriolar wall could also be a source of
adenosine under these conditions.

Closely-paired venules represent another

potential source of adenosine during sympathetic nerve stimulation. Because
first-order venular P O2 is typically 20-30 % less than first-order arteriolar PO2
under normal flow conditions [21], minimum venular PO2 should be lower than
minimum arteriolar PO2 during sympathetic nerve stimulation.

Furthermore,

adenosine can freely diffuse from the venular lumen to nearby arterioles in
vasoactive amounts [22]. In addition to these possibilities, erythrocytes within the
vessel lumen may also indirectly serve as a source of adenosine. Erythrocytes
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can release ATP in response to decreased oxygen tension [23-25], and this ATP
can be degraded by membrane-bound nucleotidases to adenosine [26].
Another issue germane to this study is that of “critical PO2”.

During

sympathetic nerve stimulation, tissue PO2 did not typically fall to the level where
one might expect a large increase in adenosine formation (Fig. 4). A study in rat
skeletal muscle provides compelling evidence that the critical extracellular PO2 at
which there is a large-scale shift from aerobic to anaerobic metabolism is less
than 3 mm Hg [27]. However, because cellular concentrations of adenosine and
AMP are in dynamic equilibrium, one would expect the more moderate reduction
in PO2 that we observed to shift this balance toward adenosine formation.
Furthermore, a recent report by Decking et al. [28] suggests that even a modest
reduction in oxygen tension suppresses cellular adenosine kinase activity,
thereby reducing the re-phosphorylation of adenosine to AMP. As a result, a
modest increase in adenosine formation can be amplified into a relatively large
increase (up to 17-fold) in local adenosine concentration [28].

This effect of

reduced oxygen on adenosine kinase may be an important mechanism for the
close matching of blood flow to oxygen consumption over a wide range of
metabolic activities [28, 29]. Most relevant to this study, previous studies in the
rat intestine have implicated adenosine as a mediator of reactive and absorptive
hyperemia under conditions where tissue PO2 may not ever fall to “critical” levels
[30, 31].
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The lack of an effect of L-NMMA on resting arteriolar tone in the intestine
(e.g., Fig. 2) is consistent with our previous findings in this preparation [2, 4]. In
light of recent direct measurements verifying that NO is continuously released
from these vessels in the resting state [32], local NOS inhibition would be
expected to reduce arteriolar diameter. However, resting arteriolar tone is the
result of vascular smooth muscle’s integration of numerous simultaneous
vasoactive signals, and the activity of local metabolic and myogenic control
mechanisms may set vascular tone at some constant and optimal level for the
tissue. These local regulatory mechanisms may be so highly developed in the
intestine that the withdrawal of any single influence (such as NO in the presence
of L-NMMA) is accompanied by a compensatory change in the activity of one or
both of these systems, thereby preserving the level of tone.
In summary, our results suggest that as arterioles constrict in response to
sympathetic nerve stimulation, a flow-dependent fall in local P O2 leads to an
increase in extracellular adenosine, which, through its interaction with endothelial
A1 receptors, stimulates NO synthesis that in turn limits the arteriolar constriction.
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Study III: Adenosine Linking Reduced Oxygen to
Arteriolar Nitric Oxide Release in the Intestine Is Not
Formed From Extracellular ATP
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SUMMARY
We have previously reported that adenosine formed in response to reduced
arteriolar and/or tissue PO 2 preserves endothelial nitric oxide (NO) synthesis
during sympathetic vasoconstriction in the rat intestine.

To more precisely

identify the site and mechanism of adenosine formation under these conditions,
we tested the hypothesis that ATP released in response to reduced O2 levels
serves as a source of adenosine. Direct application of ATP to the wall of firstorder arterioles elicited dose-dependent dilations of 15-33% above resting
diameter that were reduced by 71-80% by the 5’-ectonucleotidase inhibitor α,βmethyleneadenosine 5´-diphosphate (AOPCP, 4.5x10-5 M) or by A1 adenosine
receptor antagonism via 8-cyclopentyl-1,3-dipropylxanthine (DPCPX 4x10 -4 M in
superfusate) and completely abolished by NG-monomethyl-L-arginine (L-NMMA,
10-4 M). Under control conditions, sympathetic nerve stimulation at 3 and 8 Hz
induced arteriolar constrictions of 11±1 and 19±1 µm, respectively.

These

responses were enhanced by 58-69% in the presence of L-NMMA or when local
PO2 was maintained at resting levels. However, in the presence of AOPCP, the
enhancing effects of L-NMMA and the high-O2 superfusate on sympathetic
constriction were preserved. These results suggest that although exogenouslyapplied ATP can stimulate arteriolar NO release in the intestine largely through
its sequential extracellular hydrolysis to adenosine, this process does not
contribute to adenosine formation and sustained NO release during sympathetic
constriction in this vascular bed.
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INTRODUCTION
Nitric oxide (NO) contributes importantly to the regulation of arteriolar tone
and blood flow in the intestine (8, 9, 24). Under normal resting conditions, there
is continuous NO release from the arteriolar endothelium that is due in large part
to the shear stress associated with blood flow (9). However, we have obtained
considerable evidence that during periods of increased sympathetic nerve
activity, the constriction of intestinal arterioles is limited by sustained endothelial
NO release despite a precipitous fall in shear stress (25, 26, 33, 34). Moreover,
this modulating influence of NO on sympathetic constriction can be prevented by
minimizing the fall in microvascular and/or tissue PO2 that normally accompanies
the decrease in network blood flow (33, 34), suggesting that a reduction in local
O2 levels becomes the main stimulus for endothelial NO release under these lowshear conditions. Direct measurement with NO-sensitive microelectrodes have
verified that a reduction in blood O2 delivery is a potent stimulus for arterial NO
release in the intestine (9), and reduced O2 levels lead to increased endothelial
NO production in other vascular beds as well (1, 11, 28, 29).
We have recently determined that during sympathetic constriction in the
intestine, the fall in microvascular and/or tissue PO2 is linked to endothelial NO
release through the local formation of adenosine, which then binds to endothelial
A1 receptors that are coupled to the NO synthesis pathway. Our findings also
suggest that this adenosine is most likely formed within 50 µm of the arteriolar
wall (34). In addition to the possible release of adenosine from periarteriolar
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parenchymal cells or from cells within the arteriolar wall itself, recent studies
raise the possibility that adenosine could also be formed extracellularly via the
breakdown of ATP that is released from circulating erythrocytes when luminal O2
levels fall in either the arterioles or nearby venules (13, 15, 16). Consistent with
this possibility, microvascular endothelial cells have a high activity of extracellular
membrane ectonucleotidase, which readily degrade adenine nucleotides to
adenosine (35). The purpose of the current study was to determine if this latter
mechanism contributes to local adenosine formation, and therefore sustained
endothelial NO release, during sympathetic vasoconstriction in the intestine.

METHODS
All surgical and experimental procedures were approved by the West
Virginia University Animal Care and Use Committee. Male Sprague-Dawley rats
aged 8-9 wk (Harlan Sprague Dawley, Indianapolis, IN) were anesthetized with
sodium thiopental (100 mg/kg ip) and placed on a heating mat to maintain a 37o C
rectal temperature. To ensure adequate gas exchange, rats were intubated and
ventilated with a rodent ventilator (Harvard Apparatus, South Natick, MA). Arterial
pressure was measured from the cannulated right carotid artery with a Gould
P23 ID pressure transducer (Cleveland, OH). The small intestine was prepared
for microscopic observation as previously described (25), and continuously
superfused with a physiological electrolyte solution (in mM: 119 NaCl, 25
NaHCO3, 6 KCl, and 3.6 CaCl 2) that was warmed to 37oC and equilibrated with
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either 5% O2-5% CO 2-90% N2 to mimic normal in-vivo conditions (3) or 20% O25% CO 2-75% N2 to create an O2-enriched environment. Isoproterenol (10 mg/l;
Sigma, St. Louis, MO) and phenytoin (20 mg/l; Parke-Davis, Morris Plains, NJ)
were added to the superfusate to suppress intestinal motility.

At these

concentrations, neither agent alters resting arteriolar tone in this vascular bed
(10). With most of the preparation covered by polyvinyl film, and superfusate flow
directed beneath the film, solution PO 2 immediately above the tissue is
maintained at 40-50 mmHg under normal conditions (6).
After surgery, the rat was transferred to the stage of an Olympus BHTU
intravital microscope (Hyde Park, NY) fitted with a CCD video camera (Dage
MTI, Michigan City, IN). Video images were displayed on a Panasonic highresolution video monitor and stored on videotape for off-line analysis. Arteriolar
inner diameters were measured with a video caliper (Microcirculation Research
Institute, Texas A & M University) during videotape replay.
A bipolar platinum electrode was used to stimulate the sympathetic
postganglionic efferents running along a mesenteric artery-vein pair upstream
from the arteriole under study. The electrode and artery-vein pair were briefly
raised above the superfusate, and the nerves were stimulated with square-wave
pulses at supramaximal voltage (5-6 V) and a pulse duration of 10 ms. These
stimulation parameters elicit frequency-dependent arteriolar constrictions that are
abolished by the selective α1-receptor antagonist prazosin (27), verifying that
these responses are due to sympathetic nerve activation.
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Experimental Protocols. The overall aim of this study was to evaluate the
hypothesis that during sympathetic arteriolar constriction in the intestine, the
adenosine that links reduced local O2 levels to endothelial NO release is formed
by the sequential hydrolysis of extracellular ATP that has been released from
erythrocytes. The framing of this hypothesis gives rise to a number of testable
predictions. First, increased extracellular ATP levels in the immediate vicinity of
the arteriolar wall must reduce arteriolar tone by the same mechanism through
which endogenous adenosine acts during sympathetic constriction, i.e., the
activation of A1 adenosine receptors and stimulation of arteriolar NO release
(34). Second, this vasoactive effect of ATP must depend on the activity of 5´ectonucleotidase, the extracellular membrane-bound enzyme that converts AMP
to adenosine (the final step of the postulated adenosine formation pathway).
Third, inhibition of 5´-ectonucleotidase activity should abolish the NO-mediated
modulation of arteriolar constriction during sympathetic nerve stimulation.
Fourth, inhibition of 5´-ectonucleotidase activity should disrupt the relationship
between reduced luminal O2 levels and NO activity that we have previously
documented during sympathetic nerve stimulation (33). These predictions were
tested in the experiments described below.
The 5´-ectonucleotidase inhibitor α,β-methyleneadenosine 5´-diphosphate
(AOPCP) was used in this study. For continuous localized delivery of AOPCP to
the intestinal vasculature, the inhibitor was added to the superfusate at a
concentration of 4.5 x 10-5 M, which maximally inhibits 5´-ectonucleotidase in
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other systems (22, 23). The first series of experiments was designed to verify
that this superfusate concentration of AOPCP was sufficient to maximally inhibit
5´-ectonucleotidase in our intestinal preparation.

This was accomplished by

evaluating the effect of AOPCP on arteriolar responses to exogenous AMP,
which exerts most of its vasodilator influence only after its extracellular
conversion to adenosine via 5´-ectonucleotidase (20). A Picospritzer II ejection
system (General Valve, Fairfield, NJ) was used to apply AMP to individual firstorder arterioles. Glass micropipettes (2-3 µm inner tip diameter) were filled with
superfusate containing 10-3 M AMP and positioned with the tip lightly touching
the arteriolar wall. After a 1-min control period, AMP was applied for 1 min using
an ejection pressure of 10, 20, or 30 psi. After a 3-min recovery, this sequence
was repeated two more times so that the arteriole was challenged with all three
quantities of AMP, delivered in random order. These applications were then
repeated 10 min after addition of AOPCP to the superfusate.
The second series of experiments was designed to assess ATP’s ability to
elicit a NO-dependent reduction in arteriolar tone, and the importance of
adenosine A1 receptors in this effect. Micropipettes filled with 10-3 M ATP in
superfusate were positioned in contact with the arteriolar wall, and after a 1-min
control period, ATP was applied using ejection pressures of 10, 20, or 30 psi for
1 min. After a 3-min recovery, this sequence was repeated two more times so
that the arteriole was challenged with all three quantities of ATP, delivered in
random order.

These applications were then repeated during continuous
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exposure of the vasculature to either the NO synthase inhibitor NG-monomethylL-arginine (L-NMMA, 1x10 -4 M in superfusate), or the selective adenosine A1
receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 4x10-4 M in
superfusate).

We have recently reported that DPCPX at this concentration

virtually abolishes the responses of intestinal arterioles to directly applied
adenosine (34), verifying its effectiveness as an A1 receptor antagonist in this
preparation.
A third series of experiments was designed to determine if the vasoactive
effect of ATP can be blocked by inhibition of 5´-ectonucleotidase. As described
above, ATP was applied to the arteriolar wall by pressurized micropipette. The
arteriole was first subjected to all three quantities of ATP delivered in random
order under the normal superfusate, and then the sequence of ATP applications
was repeated in presence of 4.5x10-5 M AOPCP.

Finally, a third series of

applications was performed during continuous exposure to both AOPCP and 10-4
M L-NMMA.
A fourth series of experiments was designed to determine (1) the
relationship between 5´-ectonucleotidase activity and arteriolar NO during
periods of increased sympathetic nerve activity, and (2) the importance of 5´ectonucleotidase in the relationship between arteriolar O2 levels and NO
availability under these conditions. Experiments were performed on two groups
of rats. In the first group, during superfusion with either the normal (5% O2) or
high-O2 (20% O2) solution, a single first-order arteriole was selected for study.
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We have previously demonstrated that increased O2 delivery to these arterioles
from the high-O2 superfusate either completely prevents or greatly reduces the
fall in arteriolar O2 levels that normally accompanies sympathetic constriction
(33). After a 1-min control period, the sympathetic nerves innervating the vessel
were stimulated for 1 min at either 3 or 8 Hz. After a 3-min recovery period and a
second control period, the nerves were stimulated at the remaining frequency.
The superfusate was then changed (from normal to high-O2 or from high-O2 to
normal), and the sympathetic nerves were again stimulated at 3 and 8 Hz.
Finally, the nerve stimulations under the normal and high-O2 superfusates were
repeated in the presence of 10-4 M L-NMMA. For the second group of rats, the
same protocol was followed except that all of the nerve stimulations were
performed in the additional presence of 4.5x10-5 M AOPCP.
A fifth series of experiments was designed to determine if AOPCP alters the
inherent responsiveness of arteriolar smooth muscle to NO. Arteriolar responses
to the NO-donor sodium nitroprusside (SNP, Sigma) were assessed before and
then during exposure to AOPCP. Glass micropipettes were filled with 0.5 M SNP
in distilled water and connected to an iontophoresis current programmer (model
260, World Precision Instruments, Sarasota, FL). A retaining current of 40 nA
was used to prevent diffusion of SNP from the pipette tip, and net ejection
currents of 5, 20, and 40 nA (in random order) were used to deliver SNP to the
vessel wall. Each vessel was observed during a 2-min control period, a 2-min
application period, and a 2-min recovery period. To avoid potential complications
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related to acute changes in endogenous NO production, these experiments were
conducted in the presence of 10-4 M L-NMMA.
At the end of all experiments, adenosine was added to the superfusate (10-3
M final concentration), and passive arteriolar diameter was measured.

Data and Statistical Analysis. For each arteriole, the level of resting tone
(T) was calculated as follows: T=[(Dmax -Dc/Dmax ]x100 where Dmax is passive
diameter under adenosine, and Dc is the diameter measured during the control
period.
All data are expressed as means ± SE. Statistical analysis was carried out
using commercially available software (Sigma Stat, Jandel Scientific, San Rafael,
CA). ANOVA for repeated measures was used to compare arteriolar dilations to
AMP, ATP, and SNP before and after AOPCP, L-NMMA, or DPCPX. ANOVA for
repeated measures was also used to compare arteriolar constrictions to
sympathetic nerve stimulation before and after L-NMMA under the low and highO2 superfusates in the presence and absence of AOPCP.

For all ANOVA

procedures, the Student Newman-Keuls multiple range procedure for post hoc
analysis was used to identify differences among specific groups. Significance
was assessed at P < 0.05 for all statistical tests.
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RESULTS
In all protocols combined, a total of 58 first-order arterioles were observed in
36 rats. The rats averaged 264±4 g in body weight at 56±1 days of age, with a
mean arterial pressure under anesthesia of 100±1 mm Hg. Arteriolar resting and
passive diameters averaged 54±1 and 90±1 µm, respectively, with an average
calculated arteriolar tone of 39±1%.
Eight first-order arterioles were studied to evaluate AOPCP’s effectiveness
as a 5´-ectonucleotidase inhibitor in the rat intestine. AOPCP did not have a
significant effect on resting arteriolar diameter (55±2 µm under control conditions
vs. 57±2 µm during AOPCP exposure), but it completely abolished arteriolar
responses to directly applied AMP. AMP applied at ejection pressures of 10, 20
and 30 psi caused dilations of 6±1, 13±1, and 18±1 µm under control conditions
vs. 0±0, 0±0, and 1±1 µm in the presence of AOPCP (Fig. 1).
To assess ATP’s ability to stimulate arteriolar NO synthesis in this vascular
bed, we evaluated the effect of L-NMMA on arteriolar responses to directly
applied ATP (n = 8 vessels). L-NMMA had no significant effect on resting
arteriolar diameters (47±3 µm under control conditions vs. 48±2 µm during LNMMA exposure), but it completely abolished arteriolar responses to ATP. ATP
applied to the arteriolar wall at 10, 20, and 30 psi induced dilations of 7±1, 12±1,
and 16±2 µm under control conditions vs. 0±0, 1±1, and 1±1 µm in the presence
of L-NMMA (Fig. 2, top panel).

Eight additional vessels were studied to

determine the importance of adenosine A1 receptors in ATP’s effect on arteriolar
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tone. DPCPX had no significant effect on resting arteriolar diameter (49±3 µm
under control conditions and during DPCPX exposure), but significantly reduced
arteriolar responses to ATP. In these experiments, ATP application at 10, 20 and
30 psi induced dilations of 8±1, 14±1, and 16±2 µm under control conditions, vs.
1±1, 2±1 and 4±1 µm in the presence of DPCPX, a reduction of 75-88% (Fig. 2,
bottom panel).
Eight arterioles were studied to determine if the activity of 5´ectonucleotidase is necessary for arteriolar responsiveness to ATP (Fig. 3). In
these experiments, neither AOPCP nor L-NMMA had an effect on resting
arteriolar diameters (50±2 µm under control conditions vs. 51±2 µm with AOPCP
and 52±1 with AOPCP + L-NMMA).

ATP application at 10, 20 and 30 psi

induced dilations of 10±1, 14±1, and 17±1 µm. In the presence of AOPCP, these
responses were reduced to 2±1, 3±1 and 5±1 µm, respectively (reductions of 7080%). With the subsequent addition of L-NMMA, these residual responses were
virtually abolished (dilations of 0±0, 0±1, and 1±1 µm, respectively).
Seventeen arterioles were studied to explore the relationship between 5´ectonucleotidase activity and NO activity during periods of increased sympathetic
nerve activity. Under the normal superfusate, resting arteriolar diameter
averaged 62±1 µm and sympathetic nerve stimulation at 3 and 8 Hz induced
frequency-dependent constrictions of 11±1 and 19±1 µm, respectively (Fig. 4).
With the addition of L-NMMA, resting arteriolar diameters were unchanged (60±1
µm), but responses to each level of sympathetic nerve stimulation were
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significantly enhanced (constrictions of 19±1 and 29±2 µm at 3 and 8 Hz,
respectively). Under the high-O2 superfusate, resting arteriolar diameters were
unchanged (61±1 µm), but control responses to nerve stimulation were
significantly greater than those under the normal superfusate (constrictions of
18±1 µm at 3 Hz and 30±2 µm at 8 Hz). L-NMMA did not alter resting arteriolar
diameters (62±1 µm) under the high-O2 superfusate. However, in contrast to the
normal superfusate, L-NMMA did not enhance arteriolar responses to
sympathetic nerve stimulation under the high-O2 superfusate (constrictions of
20±1 µm at 3 Hz and 30±2 µm at 8 Hz).
Figure 5 illustrates the effect of L-NMMA on arteriolar responses to
sympathetic nerve stimulation under the normal and high-O2 superfusates in the
presence of AOPCP. As in the other experiments, neither AOPCP nor L-NMMA
altered resting arteriolar diameters in these experiments (60±1 µm under control
conditions vs. 60±1 µm in the presence of AOPCP, and 58±1 µm in the presence
of L-NMMA). Similar to the above findings, in the presence of AOPCP, arteriolar
responses to sympathetic nerve stimulation were enhanced by L-NMMA under
the normal superfusate, but not under the high-O2 superfusate.

Under the

normal superfusate, 3 and 8 Hz stimulation induced arteriolar constrictions of
10±1 and 17±1 µm under control conditions vs. 17±1 and 30±1 µm in the
presence of L-NMMA.

Under the high-O2 superfusate, 3 and 8 Hz stimulation

induced arteriolar constrictions of 19±1 and 30±1 µm under control conditions vs.
16±1 and 30±1 µm in the presence of L-NMMA.

131

To explore the possibility that erythrocytes in nearby first-order venules may
be a significant source of ATP and/or adenosine during increased sympathetic
nerve activity, we determined if proximity to a venule was a critical factor in the
limitation of arteriolar constriction by reduced P O2 or NO.

Figure 6, which is

derived from the data shown in Figures 4 and 5, illustrates the lack of a
relationship between arteriolar-venular separation distance and the effect of
either L-NMMA or increased O2 availability on arteriolar responses to
sympathetic nerve stimulation.

For either treatment, there was no significant

correlation between the magnitude of the response enhancement and arteriolevenule separation distance (see figure legend for line equations, correlation
coefficients, and p values).
Seven first-order arterioles were studied to evaluate the effect of AOPCP on
vascular smooth muscle responsiveness to NO (Fig. 7).

As in the other

experiments, AOPCP did not alter resting arteriolar diameter (57±2 µm under
control conditions vs. 58±2 µm in the presence of AOPCP).

Under control

conditions, SNP induced dilations of 11±2, 23±2, and 35±3 µm at ejection
currents of 5, 20, and 40 nA, respectively.

Exposure to AOPCP did not

significantly alter these responses (dilations of 12±2, 22±3, and 32±3 µm at
ejection currents of 5, 20, and 40 nA).
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Figure 1. Arteriolar responses to AMP applied via pressurized micropipette
directly to the arteriolar wall under the normal superfusate, before (closed bars)
and then during (open bars) exposure to 4.5 x 10-5 M AOPCP. All data are
paired. n = 10 vessels. *P<0.05 vs. control.
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Figure 2. Arteriolar responses to ATP applied via pressurized micropipette,
before (closed bars; both panels) and then during exposure to 10-4 M L-NMMA
(open bars) or 4 x 10-4 M DPCPX (hatched bars). Data within each group of
experiments (n = 8 vessels) are paired. *P<0.05 vs. control.
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Figure 3. Arteriolar responses to ATP applied via pressurized micropipette
under the normal superfusate, before (closed bars) and then during exposure to
4.5 x 10-5 M AOPCP (hatched bars) and then during exposure to 4.5 x 10-5 M
AOPCP + 10-4 M L-NMMA (open bars). All data are paired. n = 8 vessels.
*P<0.05 vs. control; †P<0.05 vs. AOPCP.

135

Normal Superfusate
0

3 Hz

8 Hz

High-O2 Superfusate
3 Hz

8 Hz

Diameter Change From Control (µm)

-5

-10

-15

*

-20

*

*

-25

-30

-35

Control
L-NMMA

†

†
†

Figure 4. Effect of L-NMMA on arteriolar responses to 3 and 8 Hz sympathetic
nerve stimulation under normal superfusate (left panel) and high-O2 superfusate
(right panel). All data are paired. n = 8 vessels. *P<0.05 vs. control response to
3 Hz stimulation under normal superfusate; †P<0.05 vs. control response to 8 Hz
stimulation under normal superfusate.
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Figure 5. Effect of L-NMMA on arteriolar responses to 3 and 8 Hz sympathetic
nerve stimulation during continuous exposure to 4.5x10 -5 M AOPCP under
normal superfusate (left panel) and high-O2 superfusate (right panel). All data
are paired. n = 9 vessels.
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Figure 6. First-order linear regression plots of the increase in arteriolar
sympathetic constriction vs. arteriole-venule separation distance at nerve
stimulation frequencies of 3 Hz (panels A and C) or 8 Hz (panels B and D) during
exposure to L-NMMA (panels A and B) or to the high-O2 superfusate (panels C
and D). r = 0.03, P = 0.91, and f = 79.3 + .11x for panel A; r = 0.42, P = 0.09,
and f = 42.9 + .87x for panel B; r = 0.23, P = 0.38, and f = 65.8 + .83x for panel
C; r = 0.42, P = 0.10, and f = 50.7 + .83x for panel D. All data are paired. n = 17
vessels.
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Figure 7. Arteriolar responses to iontophoretically applied SNP under normal
superfusate before (closed bars) and during exposure to AOPCP (open bars).
All data are paired. n = 7 vessels.
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DISCUSSION
Our recent investigations of this vascular bed have led us to conclude that
during periods of increased sympathetic outflow to the arterioles, a flowdependent fall in local PO2 leads to local formation of adenosine, which in turn
maintains arteriolar NO synthesis in the face of reduced shear stress via
activation of endothelial A1 receptors (34). In an attempt to determine the site of
adenosine formation under these conditions, we sought in this study to test the
hypothesis that ATP, released from erythrocytes in response to reduced O2
levels, is sequentially hydrolyzed to adenosine via extracellular nucleotidase
activity.
Recently, Ellsworth has reported that a reduction in PO2 from 85 to 35 mm
Hg increases ATP release from rat erythrocytes by more than 75% (15). We
have found that 3-8 Hz sympathetic nerve stimulation reduces blood flow in the
intestine by 33-66% (23), which causes first-order arteriolar wall PO2 to fall from
67±3 mm Hg to as low as 41±6 mm Hg (33). Since arteriolar wall PO2 is almost
identical to luminal P O2 (14), it seems possible that under our experimental
conditions, there could have been an increase in erythrocyte ATP release similar
to that reported by Ellsworth. Erythrocytes in nearby venules could also be the
source of ATP under these conditions. We have not measured first-order venular
PO2 in the rat intestine during sympathetic nerve stimulation, but measurements
made by others in this preparation under similar experimental conditions (7, 36)
suggest that the resting PO2 of these venules is probably around 50 mm Hg, or
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roughly 25% below that of the paired first-order arterioles.

Therefore, during

sympathetic nerve stimulation, we would expect venular lumen PO2 to fall as low
as if not lower than the minimum P O2 we measured in the nearby arterioles.
Chemical communication can occur between paired arterioles and venules (17,
21, 37), and adenosine in particular can readily diffuse from venules to arterioles
in vasoactive amounts, even when the vessels are separated by more than 150
µm (21). In the current experiments, the adenosine responsible for stimulating
endothelial NO synthesis is most likely formed within 50 µm of the arteriolar wall
(34). Because most of the arterioles we studied were within 50 µm of a paired
venule (mean separation distance = 29±5 µm), it is possible that at least some of
the adenosine responsible for stimulating arteriolar NO synthesis during
sympathetic constriction could have either diffused from the venular blood or
have been formed from ATP at the venular wall.

However, we found no

correlation between arteriole-venule separation distance and the effect of either
L-NMMA or the high-O2 superfusate on arteriolar sympathetic constriction (Fig.
6). Therefore, it appears unlikely that a significant fraction of the vasoactive pool
of adenosine (or its hypothesized precursor, ATP) originated within the venules.
Consistent with the possibility that ATP from arteriolar erythrocytes serves
as an extracellular source of adenosine in this preparation, we found that ATP
applied to the arteriolar wall causes a NO-dependent dilation (Fig. 2, top panel)
that is largely due to A1 receptor activation (Fig. 2, bottom panel) and that largely
depends on 5’-ectonucleotidase activity (Fig. 3). Taken together, these findings
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suggest that in the intestine, extracellular ATP in the immediate vicinity of the
arteriolar wall can stimulate arteriolar NO release through the ultimate conversion
of AMP to adenosine. The smooth muscle of intestinal and mesenteric arterioles
contains P 2x purinergic receptors that should elicit vasoconstriction when
stimulated by ATP (19, 31). However, the amounts of ATP that we applied to the
arteriolar wall were relatively low (the highest amount causing only about 35% of
maximal dilation) and did not cause even a transient constriction. Since most of
that ATP was quickly hydrolyzed to adenosine (Figure 3), the amount of
unhydrolyzed ATP was presumably insufficient to activate the P2x receptors.
Consistent with this interpretation, we found in preliminary experiments that
application of ATP in higher quantities did cause arteriolar constriction
(unpublished results).
If endogenous ATP were sequentially hydrolyzed to adenosine as local O2
levels fell during sympathetic constriction, then inhibition of 5’-ectonucleotidase
should have abolished the limiting influence of NO on arteriolar constriction
because, as mentioned above, adenosine serves to link the fall in O2 to NO
production (34). A comparison of Figures 4 and 5 reveals that AOPCP had no
effect on the ability of L-NMMA to enhance arteriolar responses to sympathetic
nerve stimulation, or on the abrogation of L-NMMA’s effect under the high-O2
superfusate. Therefore, these results suggest that extracellular ATP, regardless
of its origin, probably does not serve as a significant source of the adenosine that
sustains arteriolar NO release under the current experimental conditions.
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For the correct interpretation of our findings, it was critical that we verify the
specificity of our antagonists and also demonstrate that vascular smooth muscle
responsiveness to NO was not altered by any of our treatments. Our finding that
AOPCP completely abolished arteriolar responses to AMP (Fig. 1) confirms the
efficacy of AOPCP as a 5’-ectonucleotidase inhibitor in the intestinal
microcirculation, and is consistent with studies conducted in other vascular beds
(22, 23). In addition, we have previously demonstrated that 4 x 10-4 M DPCPX
completely abolishes arteriolar responses to A1 receptor agonists in this
preparation (34). The preservation of normal arteriolar responses to SNP in the
presence of AOPCP (Fig. 7) argues against the possibility that AOPCP alters the
vascular smooth muscle responsiveness to NO under our experimental
conditions.

Finally we have previously demonstrated that neither the high-O2

superfusate

nor

DPCPX

has

any

effect

on

vascular

smooth

muscle

responsiveness to NO (33, 34).
Another important observation in this study is the lack of an effect of LNMMA on steady-state arteriolar tone, which contrasts with findings in skeletal
muscle (1, 24), but is consistent with our previous findings in this vascular bed
(26, 33, 34).

In light of recent direct measurements verifying that NO is

continuously released from these vessels in the resting state (9), local NOS
inhibition would be expected to reduce arteriolar diameter. In fact, we routinely
did see a transient reduction in arteriolar diameter within the first few minutes of
L-NMMA exposure, but then these vessels regained their initial resting diameter.
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This inability of L-NMMA to produce a sustained reduction in arteriolar diameter
may reflect the fact that resting arteriolar tone results from the integration of
numerous simultaneous vasoactive signals by the vascular smooth muscle.
Local vascular regulatory mechanisms may be so highly developed in the
intestine that the removal of any single influence (such as NO in the presence of
L-NMMA) is accompanied by a compensatory change in the activity of any of
these systems, thereby re-establishing the initial level of resting tone.
We also found that resting arteriolar diameters were not altered by exposure to
the high-O2 superfusate, which is consistent with our earlier findings in this
preparation (33, 34). This may be due to the fact that the high-O2 superfusate,
which minimizes the fall in both arteriolar wall and local tissue PO2 during
sympathetic constriction, does not have any significant effect on these PO2 values
under resting conditions (33, 34). This is because O2 levels in the arteriolar wall
and immediately adjacent parenchymal tissue are overwhelmingly influenced by
luminal blood O2 delivery during normal flow conditions, with extraluminal O2
delivery from the superfusate only becoming important when luminal blood flow falls
during sympathetic (4).

Since resting wall and periarteriolar PO2’s were not

changed under the high-O2 superfusate, it is understandable that no arteriolar
constriction occurred under these conditions.
Since molecular O2 is a co-substrate for all NOS isoforms (18, 38), the
reduction in arteriolar wall PO2 that accompanies sympathetic constriction (33)
might have been expected to limit arteriolar NO production despite increased
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local adenosine levels.

However, our previous measurements indicate that

during sympathetic stimulation at the frequencies used here, arteriolar wall PO2
never approaches the level reflecting the Km of O2 for either isolated eNOS (6
mm Hg) (32) or eNOS in intact endothelial cells (38 mm Hg) (38). Therefore, the
reduction in arteriolar wall PO2 during sympathetic constriction was probably not
sufficient to limit endothelial NO synthesis in the current study. Our observations
suggest that as arteriolar wall PO2 falls, NO synthesis may in fact change in a
biphasic manner. A fall in PO2 from resting levels could initially stimulate NO
synthesis through adenosine formation, whereas a continued fall to lower levels
would begin to suppress NO synthesis as O2 becomes limited as a NOS cosubstrate.
Although the current results do not suggest a contribution of extracellular
ATP hydrolysis to adenosine formation during sympathetic nerve stimulation in
the intestine, they do provide important, albeit indirect, information about the
nature of adenosine release under our experimental conditions. Based on our
previous investigations, we concluded that the adenosine involved in stimulating
NO release during sympathetic stimulation must come from a site within 50 µm of
the vessel wall (34).

As reported here, ATP released from arteriolar and/or

venular erythrocytes does not appear to contribute importantly to the formation of
adenosine under the current experimental conditions, nor is there any evidence
of the venular blood or venular wall cells serving as direct sources of adenosine.
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This leaves the arteriolar wall and/or the periarteriolar parenchymal cells as the
most likely sources of adenosine under these conditions (11, 12).
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GENERAL DISCUSSION
The overall objective of this dissertation project was to determine if reduced
O2 tension serves as a stimulus for endothelial NO synthesis during neurogenic
constriction in the rat intestine, and if so, to determine the mechanism by which
reduced O2 tension promotes NO synthesis under these conditions.
In the first study, we evaluated the hypothesis that a flow-dependent fall in
arteriolar wall PO2 serves as a stimulus for endothelial NO synthesis during
periods of increased sympathetic outflow to the arteriolar network of the intestine.
Numerous studies have found that reduced O2 tension can promote the release
of endothelium-derived vasoactive factors (Busse et al., 1983; Pohl and Busse,
1989; Myers et al., 1991; Okada, 1991; Gräser and Rubanyi, 1992; Messina et
al., 1992; Park et al., 1992; Busse et al., 1993; Fredricks et al., 1994; Blitzer et
al., 1996; Jimenez, 1996; Ward, 1996; Bryan and Marshal, 1999a; Bryan and
Marshall, 1999b). In isolated rat aorta, Pohl and Busse (1989) demonstrated that
hypoxia stimulates endothelial NO release. Similarly, hypoxia has been shown to
increase NO synthesis in a variety of vessels and vascular beds, including rat
aorta (Gräser and Rubanyi, 1992), guinea pig heart (Park et al., 1992), bovine
pulmonary artery (Hampl et al., 1995), pig heart (Xu et al., 1995; Jimenez et al.,
1996), human forearm (Blitzer et al., 1996), dog diaphragm (Ward, 1996), and rat
intestine (Bohlen and Nase, 2000; Bohlen and Nase, 2001). In accordance with
these studies, we found that limiting the flow-dependent fall in arteriolar wall PO2
that normally accompanies neurogenic constriction significantly enhances the
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arteriolar response to sympathetic nerve stimulation and renders this response
no longer sensitive to NOS inhibition. Furthermore, the high-O2 superfusate had
no effect on vascular smooth muscle responsiveness to NO or on arteriolar wall
oxidant activity. Taken together, these results suggest that a flow-dependent fall
in arteriolar wall PO2 promotes endogenous NO synthesis during periods of
increased sympathetic nerve activity in the rat intestine.
Equipped with the results of the first study, we sought to evaluate the
mechanism by which reduced O2 tension promotes NO synthesis.

Some

investigators have reported that the vascular endothelium is itself sensitive to
local O2 levels, and that reduced PO2 directly increases the release of endothelial
NO (Park et al., 1992; Xu et al., 1995). However, we chose to test an alternative
hypothesis, namely, that a local decrease in oxygen tension indirectly stimulates
endothelial NO release through adenosine formation. Many investigators have
shown that reductions in O2 tension lead to increased adenosine levels
(Raatikainen et al., 1994; Cohen et al., 1995; Decking et al., 1997), and
adenosine has been shown to stimulate NO synthesis in some vascular beds
(Hein et al., 1999; Peralta et al., 1999). Danialou et al. (1997) reported that
activation of A1 adenosine receptors stimulates arteriolar NO synthesis in the rat
diaphragm. Similarly, Bryan and Marshall (1999a; 1999b) found that inspiration
of 8% O2 promotes adenosine release from the endothelium of resistance
vessels, and that this adenosine then acts in an autocrine fashion to
hyperpolarize the endothelial cell membrane via activation of A1 receptor-coupled
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KATP channels. However, Bryan and Marshall’s use of 8% O2 to induce systemic
hypoxia may have produced arteriolar wall O2 tensions that were considerably
less than those achieved by sympathetic nerve stimulation in our first study.
Furthermore, the interpretation of their findings may be complicated by reflex
changes in sympathetic nerve activity due to decreased arterial O2 levels (Hoka
et al., 1992).

The second study was designed to avoid such influences by

limiting the reduction in O2 tension to the intestine.
The “critical P O2” that is traditionally considered necessary for the
conversion from aerobic to anaerobic metabolism has been reported to be less
than 3 mm Hg in rat skeletal muscle (Richmond et al., 1999).

Because our

measured arteriolar wall PO2 remained well above this “critical PO2” during
sympathetic constriction, it seemed unlikely that the wall of these vessels could
produce a significant amount of adenosine under the conditions of our study.
However, cellular concentrations of adenosine and AMP are in dynamic
equilibrium, and even a moderate reduction in PO2 could shift this balance toward
adenosine formation.

Recently Decking and colleagues (1997) reported that

reductions in O2 tension suppress cellular adenosine kinase activity. As a result,
a modest increase in adenosine formation can be amplified into a relatively large
increase (up to 17-fold) in local adenosine concentration (Decking et al., 1997).
This effect of reduced oxygen on adenosine kinase may be an important
mechanism for the close matching of blood flow to oxygen consumption over a
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wide range of metabolic activities (Decking et al., 1997; Arch and Newsholme,
1978).
The results of the second study clearly indicate that adenosine serves as a
link between reduced local O2 tension and arteriolar NO synthesis during
neurogenic constriction in the rat intestine, and that the origin of this adenosine is
most likely within 50 µm of the arteriolar wall. To establish a link between tissue
oxygenation and adenosine formation, I measured tissue PO2 at a site deemed
capable of releasing adenosine that would yield NO-dependent arteriolar
dilations, 25 µm away from the arteriolar wall. Sympathetic constriction resulted
in a fall in tissue P O2 that was significantly greater than that reported for the
arteriolar wall in the first study. This significantly greater reduction in tissue PO2
could allow for more adenosine formation out in the parenchyma than within the
arteriolar wall. Similar to the results of the first study, the limiting influence of NO
on sympathetic constriction was lost in the presence of the high-O2 superfusate.
However, unlike the first study, where the high-O2 superfusate only limited the fall
in arteriolar wall PO2, the high-O2 superfusate completely abolished the flowdependent fall in tissue PO2 in the second study. These results suggest that
tissues other than the arteriolar wall are more likely sites of adenosine formation
under these conditions.

Abolition of local adenosine activity via accelerated

adenosine metabolism or blockade of microvascular A1 receptors also enhanced
arteriolar response to sympathetic nerve stimulation and rendered them
insensitive to NOS inhibition in a manner that was not altered by tissue
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oxygenation. Collectively, the results of the first two studies suggest that a flowdependent fall in local PO2 leads to an increase in extracellular adenosine, which,
through its interaction with endothelial A1 receptors, stimulates NO synthesis that
in turn limits the arteriolar response to sympathetic nerve activity.
Adenosine plays other important roles in this vascular bed, primarily in
relation to local blood flow control. For instance, it has been suggested that
adenosine is one of, perhaps, several mediators of intestinal functional
hyperemia (Proctor, 1986). In his study, Proctor (1986) reported that treatment
with either adenosine deaminase or the non-selective adenosine receptor
antagonist theophylline significantly reduces, but does not eliminate, the
intestinal vasodilation elicited by nutrient absorption.

Furthermore, neither of

these treatments affected basal hemodynamics, suggesting that resting intestinal
blood flow is not influenced by adenosine.

Pawlik and colleagues (1993)

demonstrated that the use of either adenosine deaminase or theophylline also
significantly reduces the dilatory response of intestinal arteries to brief periods of
occlusion, suggesting that adenosine is a mediator of reactive hyperemia.
Similarly, Buckley and coworkers (1988) reported that theophylline significantly
reduced intestinal blood flow autoregulation in the pig.

Finally, Kaminski and

Proctor (1989) reported that topical application of adenosine to the serosa of
partially

isolated

jejunal

segments

attenuates

the

intestinal

no-reflow

phenomenon, reduces a biochemical index of neutrophil activation, and limits the
histological changes associated with reperfusion.
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The ubiquitous release of adenosine under low O2 conditions and its ability
to stimulate NO synthesis in the intestinal vascular bed indicates that adenosine
may also link reduced PO2 to NO synthesis during sympathetic nerve stimulation
in other vascular beds. However, the intricate nature of this pathway suggests
that it may be more prevalent in tissues where metabolic flow control
mechanisms are well developed.

For example, numerous investigators have

reported a role for adenosine in the regulation of blood flow in tissues such as
heart and brain, (Schrader et al., 1977; Olsson et al., 1979; Simpson and Phillis,
1991;). One likely exception to this postulate is the kidney, where adenosine has
been shown to produce vasoconstriction and vasodilation at low and high
concentrations, respectively (Inscho, 1996). In vascular beds where metabolic
flow control mechanisms are not well developed, one or more key steps in this
pathway may be absent. For instance, local NO activity does not limit arteriolar
responses to sympathetic nerve activity in the rat cutaneous vasculature (Häbler
et al., 1997).
In addition to regional variation among different vascular beds, there may be
developmental changes that affect the ability of this pathway to modulate
arteriolar tone.

For instance, Linderman and Boegehold (1998) found that

arterioles in the rat spinotrapezius muscle did not express basal NO release or
NO-dependent modulation of sympathetic tone until 7-8 weeks of age. Since all
of the animals used in the current project were 1-2 weeks older than those
studied by Linderman and Boegehold, it is difficult to speculate as to whether the
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intestinal circulation may have undergone a similar developmental change.
However, based on the similarities in growth and development between the
intestine and skeletal muscle, it seems likely that the intestine would have
undergone a similar functional change. During juvenile growth, spinotrapezius
muscle size doubles and this tissue enlargement is typically accompanied by
extensive growth of the arteriolar network (Linderman and Boegehold, 1996).
Similarly, the rat intestine more than doubles in size during juvenile growth and is
accompanied by an elongation of the preexisting vasculature (Unthank and
Bohlen, 1987). Due to structural changes such as these, the microvasculature of
both tissues would be subjected to an ever-changing hemodynamic milieu, which
may serve as the stimulus for the development of various microvascular control
mechanisms. Therefore, the delayed appearance of this particular microvascular
control mechanism in the spinotrapezius muscle may be the result of the
subsequent microvascular development previously described by this laboratory.
In the third study, I sought to ascertain the origin of the adenosine that links
the fall in local O2 tension to endothelial NO release. Based on the results of the
second study, I decided to evaluate two potential sites of adenosine formation
that were typically within 50 µm of the arteriolar wall. Within this distance there
are a number of potential sites of adenosine formation including the wall itself,
the neighboring parenchymal cells, the nearby paired venule, and the
erythrocytes circulating within the arteriolar and/or venular lumen. In the third
study, we evaluated the hypothesis that the extracellular conversion of ATP to
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adenosine is necessary to ensure endothelial NO synthesis in rat intestinal
arterioles under our experimental conditions. However, the results of this study
indicate that the extracellular conversion of ATP to adenosine is not necessary
for continued NO synthesis under these conditions.
In addition to evaluating the importance of the extracellular conversion of
ATP to adenosine during sympathetic constriction, we indirectly evaluated the
possibility that the neighboring first-order venules serve as an additional source
of adenosine under the current conditions. With most of the arterioles studied in
these experiments located within 50 µm of a paired venule, it is possible that at
least some of the adenosine responsible for sustaining arteriolar NO synthesis
during sympathetic constriction could have diffused from the venules to the
nearby arterioles. However, we found no correlation between arteriole-venule
separation distance and the effect of L-NMMA or the high-O2 superfusate on
arteriolar responses to sympathetic nerve stimulation.

Therefore, it appears

unlikely that a significant fraction of the vasoactive pool of adenosine originated
within the venules.
Although these results suggest that extracellular ATP hydrolysis does not
contribute to adenosine formation during sympathetic nerve stimulation in the
intestine, they do provide indirect information about the nature of adenosine
release under these experimental conditions. Based on the results of the second
study, I concluded that the adenosine involved in stimulating NO release during
sympathetic stimulation must come from a site within 50 µm of the vessel wall.
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Within this range, possible sources of adenosine include the arteriolar wall itself,
the nearby parenchymal cells, the paired venule, and ATP released from
erythrocytes circulating within the arteriolar and venular lumen.

As reported

here, ATP released from arteriolar and/or venular erythrocytes does not appear
to contribute importantly to the formation of adenosine under the current
experimental conditions, nor is there any evidence of the venular blood or
venular wall cells serving as direct sources of adenosine. The elimination of
these two potential sources leaves the arteriolar wall and/or the periarteriolar
parenchymal cells as the most likely sites of adenosine release under these
conditions (see Figure 2 next page for summary).
In conclusion, the results of this dissertation project demonstrate that a flowdependent fall in local O2 tension limits the arteriolar response to sympathetic
nerve stimulation in the rat intestine by promoting the release of adenosine,
which subsequently stimulates endothelial NO release through its interaction with
A1 receptors. Furthermore, these results indicate that neither the extracellular
conversion of ATP to adenosine nor the release of adenosine from nearby paired
venules contribute importantly to the vasoactive pool of adenosine under these
conditions.

163

PO2

Blood flow

(+)
ATP

ADP

AMP
aden osin e
ki n ase

5´
nu cleotidase

Adenosine

NO
Endothe lia l A1
receptor

Nearby
Parenchy mal cell
Art eriolar Wall

Figure 1. Schematic representation of the two most likely sources of adenosine
under the conditions of this project.
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